US20110251669A1 - Metallic implant which is degradable in vivo - Google Patents
Metallic implant which is degradable in vivo Download PDFInfo
- Publication number
- US20110251669A1 US20110251669A1 US12/897,967 US89796710A US2011251669A1 US 20110251669 A1 US20110251669 A1 US 20110251669A1 US 89796710 A US89796710 A US 89796710A US 2011251669 A1 US2011251669 A1 US 2011251669A1
- Authority
- US
- United States
- Prior art keywords
- vessel support
- stent
- vivo
- corrosion
- magnesium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/148—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/1204—Type of occlusion temporary occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12104—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in an air passage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
- A61B17/68—Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
- A61B17/84—Fasteners therefor or fasteners being internal fixation devices
- A61B17/86—Pins or screws or threaded wires; nuts therefor
- A61B17/866—Material or manufacture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/04—Metals or alloys
- A61L27/042—Iron or iron alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/04—Metals or alloys
- A61L27/047—Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/022—Metals or alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
- A61B17/68—Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00004—(bio)absorbable, (bio)resorbable, resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30062—(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00011—Metals or alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00011—Metals or alloys
- A61F2310/00017—Iron- or Fe-based alloys, e.g. stainless steel
Definitions
- the present invention relates to implants made of metallic materials for use in the human or animal body.
- Implants of this type hare in principle been known for a long time.
- the first implants were developed for orthopaedic purposes, for example screws and nails for fixing bone fractures. These initially consisted of relatively simple iron alloys which were prone to corrosion under in vivo conditions. The corrosion led to metals being released as ions in the direct vicinity of the bone providing an unwanted stimulus for the growth of bone tissue. The bone grew more than is actually wanted and necessary. This led to damage to healthy bone material.
- metallic implants are known in the specialty of vascular surgery and cardiology, angiology and radiology. These implants comprise, for example, endoluminal and vessel supports (stents) for treating lesions. These supports are used, for example, for widening and maintaining the lumen of narrowed vessels by keeping the vessel lumen at an appropriately optimal internal diameter using a balloon catheter (balloon expandable) or self-expanding from the vessel lumen outwards.
- the implant is intrinsically necessary only until the diseased vessel is able permanently to maintain the necessary diameter under its own power due to biological repair processes. This is generally the case about 4 weeks after implantation.
- biodegradable implants are made of synthetic materials. There is disclosure therein of coating an orthopaedic implant with polymethylmethacrylate which is biodegradable. Other synthetic materials comprise polylactide and polyglycolic esters.
- EP 0006544 B1 discloses a biodegradable ceramic material based on calcium phosphate, which is likewise used for coating metallic implants.
- WO 81/02668 discloses an orthopaedic implant which comprises a corrosion-resistant metallic basic component and a biodegradable intermediate metallic layer for the bone contact region.
- This intermediate layer forms together with the basic component an electrochemical cell and generates an electrical voltage which promotes bone growth.
- the surface layer which may, for example, consist of silver alloys is degraded. This leads to the desired effect, that bone growth is beneficially influenced for as long as necessary and then, after complete degradation of the surface coating, the electrical stimulus declines.
- biodegradable polymer-based substances are used in vascular surgery. Their mechanical properties on the one hand and the subsequent foreign-body reaction during the biodegradation on the other hand lead to them is being unsuitable on their own as material for implantation. Metallic materials/alloys have favourable mechanical properties (elasticity, deformability, stability) while being less bulky, which is an important precondition for administration through thin-lumen guide systems in the transcutaneous procedure.
- a medical implant made of metallic material, characterized in that the material is degradable in vivo through corrosion.
- the medical implant is fabricated from a metallic material which is degradable in vivo through corrosion, in the first place the mechanical advantages of metallic materials are present.
- the corrosive degradation of the implant within a time scale which can be set by the choice of material prevents, on the other hand, the adverse long-term effects of the metallic foreign body occurring.
- the material is pure iron, where appropriate with a content of up to 7% carbon or an alloy or a sintered metal, the main constituent of which is selected from the group of alkali metals, of alkaline earth metals, iron, zinc or aluminium. Magnesium or iron is currently preferred as main constituent.
- the biological, mechanical and chemical properties of the materials can be beneficially affected if a subsidiary constituent is provided in the form of manganese, cobalt, nickel, chromium, copper, cadmium, leads tin, thorium, zirconium, silver, gold, palladium, platinum, rhenium, silicon, calcium, lithium, aluminium, zinc, iron, carbon or sulphur.
- the material preferred overall at present is either an alloy of magnesium with a content of up to 40% lithium plus addition of iron, or an iron alloy with a small content of aluminium, magnesium, nickel and/or zinc.
- Corrosion which is particularly satisfactory at the start of the degradation period is afforded by an alloy or a sintered metal made of approximately equal parts of zinc and irons.
- lithium 0-40% lithium, 0-5% iron and less than 5% other metals or rare earths;
- aluminium 2-5% aluminium, 0-12% lithium and 1-4% rare earths, in particular cerium, lanthanum, neodymium and/or praseodymium,
- Magnesium alloys of these types are available, for example, under the names AZ91D, AM50A and AE42.
- the design of the medical implant has several basic variants.
- the basic component provided for a vessel support is a tubular structure with additional processing.
- Advantageous occlusion systems e.g. ductus arteriosus, congenital and acquired septal defects, arteriovenous shunt connections
- ductus arteriosus congenital and acquired septal defects, arteriovenous shunt connections
- occluders are passively and/or actively unfoldable umbrella forms, helices or complex components.
- the invention is also applicable to occluders as systems for occluding connections between cavities, vessels or duct systems.
- implant as fastening or supporting device for temporarily fixing tissue parts in the form of implants or transplants.
- the thickness of the material is chosen as a function of the composition of the materials so that the degradation or corrosion process in vivo is essentially complete in between 5 days and 6 months, in particular between 2 weeks and 8 weeks.
- the implant is designed as orthopaedic implant, as implant for dentistry, for surgery to the upper abdomen or for accident surgery, in particular for treating the human body, in which case the alloy must be chosen so that bone growth is not adversely or excessively influenced.
- Orthopaedic implants according to the invention in the form of nails, screws or plates can be designed to degrade after the treated bone fracture has set and not require removal in a second operation.
- a stent according to the invention is fabricated from a tubular basic component of the metallic material and subsequent processing.
- the mechanical structure of stents of this type is known, for example, from EP 0221570 B1, in which case the material is, however, a corrosion-resistant stainless steel.
- the material is either an alloy having magnesium as main constituent and, where appropriate, the subsidiary constituents lithium, iron, zinc and traces of nickel, or an alloy having iron as main constituent and the subsidiary constituents chromium and nickel plus, where appropriate, traces of other additions.
- the percentage composition of the magnesium alloy should be approximately in the region of 50-98% magnesium, 0-40% lithium, 0-5% iron and less than 5% other metals, and that of the iron alloy approximately in the region of 88-99% iron, 0.5-7% chromium and 0.5-3.5% nickel plus less than 5% other metals.
- the wall thickness of the stent struts should be between 50 and 100 mm after the processing.
- the stent according to the invention will be inserted in a manner known per se using a balloon catheter into a pathologically narrowed blood vessel and there dilated or released as self-expanding stent, in which case it keeps the blood vessel at the required diameter.
- a restenosis remaining without stent implantation (recoil) and/or a tissue tear induced by the dilatation are effectively treated.
- the stent is covered by intimal tissue and initially retains its supporting function.
- the blood vessel acquires a new intrinsic stability through tissue growth as a result of its own repair processes in the region of the implanted stent.
- the vessel lumen is stabilized at an optimal level.
- the choice of the alloy material together with the chosen wall thickness result, on the other hand, in the stent gradually being degraded in the wall of the blood vessel and being present only in traces after 4-12 weeks.
- the disadvantages of a permanent implant are decreased or eliminated by the present invention. Such disadvantages include local and possibly systemic reactions, impedance of the self-regulation of the affected vessel segment, stress on the metal due to pulsations leading to fatigue fractures and, in the case of large-lumen implants including occlusion systems such as umbrellas, may lead to new medical problems.
- An occlusion system (umbrella) according to the invention is fabricated from a metallic skeleton to which a plastic umbrella is affixed.
- Umbrellas of this type are known, for example made of the alloy MP35N or Nitinol.
- Occlusion Systems of this type are used to occlude defects in septa of the heart.
- the wall thickness of the metallic framework is about 500 mm.
- the umbrella is folded up in a manner known per se and released in the defect which is to be occluded. Within 3-4 weeks, the umbrella is covered by endogenous tissue and acquires a new intrinsic stability thorough this tissue growth.
- the choice of the alloy material together with the tissue wall thickness results in the metallic framework being degraded within 4 weeks to a few months and being present only in traces after one year.
- the plastic content of the umbrella remains, which is not critical because of the flexibility of the material.
- the degradation of the metallic portion has the advantage by comparison with known umbrellas that, even if there are unpredicted stresses, e.g. associated with traffic accidents, there is no longer a risk of vessel walls being pierced.
- the advantage according to the invention is achieved even if the degradation results initially in mechanical instability of the framework.
- EXAMPLE 3 HELIX FOR OCCLUDING VESSELS (OCCLUDER)
- a helix (coil) according to the invention is fabricated from a metallic material wound helically, and the helix is prefixed.
- the diameter of the initial winding is 0.1-1 mm depending on the vessel to be occluded.
- Helices (coils) of this type are known, for example made of Nitinol, platinum alloys or tungsten alloys.
- the material is an alloy with iron as main constituent and with subsidiary constituents nickel and/or chromium and traces of magnesium and zinc.
- the occluding helix (coil) is inserted in the extended state in a cardiac catheter in a manner known per se and is advanced through the latter as far as the vessel to be occluded.
- the helix is released from the cardiac catheter it resumes its previous shape and occludes, through its lumen and its thrombogenicity, which can be increased by Dacron or other fibres, the vessel to be occluded.
- the occlusion mechanism acquires a new intrinsic stability.
- the administered helix is gradually degraded so that only traces of the implanted material are still present after about one year.
- the exemplary embodiments mentioned above can be fabricated both with use of magnesium alloys and with use of iron alloys.
- the materials are not known to have toxic effects at the concentrations to be expected.
- Magnesium alloys have the advantage that it is possible to select very accurately the degradation rate to be expected in vivo by a suitable choice of the other alloy constituents. In addition, magnesium is physiologically very well tolerated. Iron alloys are advantageous in terms of the mechanical stability, which is manifested by the small wall thicknesses possible for the implants. The alloy material can therefore be selected depending on the case for which it is used.
- the present invention provides medical implants which are made of a metallic material, characterized in that the material is degradable in vivo through corrosion.
- Metallic materials from which implants of the invention can be made are characterized in that the primary material is pure iron or an alloy whose main constituent is selected from the group comprising the following: alkali metals, alkaline earth metals, iron, zinc, aluminium.
- the primary metallic material from which implants of the invention can be made is further characterized in that the material contains magnesium, iron, or zinc as main constituent.
- a medical implant according to the invention is characterized in that the metallic material contains iron and 0.5 to 7% carbon.
- a medical implant according to the invention is characterized in that the metallic material contains iron and zinc in approximately the same concentration.
- a medical implant according to the invention is characterized in that the metallic material contains as subsidiary constituents one or more elements from the group comprising the following: Mn, Co, Ni, Cr, Cu, Cd, Pb, Sn, Th, Zr, Ag, Au, Pd, Pt, Re, Si, Ca, Li, Al, Zn, Fe, C, S.
- the metallic material contains 50-98% magnesium, 0-40% lithium, 0-5% iron and less than 5% other metals or rare earths.
- the metallic material contains 79-97% magnesium, 2-5% aluminium, 0-12% lithium and 1-4% rare earths, in particular cerium, lanthanum, neodymium and/or praseodymium.
- the alloy is characterized in that the material contains 85-91% magnesium, 6-12% lithium, 2% aluminium and 1% rare earths. In yet other embodiments, the metallic material contains 86-97% magnesium, 0-8% lithium, 2%-4% aluminium and 1-2% rare earths.
- the metallic material contains 8.5-9.5% aluminium, 0.15%-0.4% manganese, 0.45-0.9% zinc and the remainder to 100% magnesium.
- the metallic material of a medical implant according to the invention is characterized in that the material contains 4.5-5.3% aluminium, 0.28%-0.5% manganese and the remainder to 100% magnesium.
- the metallic material is characterized in that the material contains 55-65% magnesium, 30-40% lithium and 0-5% other metals and/or rare earths.
- the metallic material is characterized in that the material contains 88-99.8% iron, 0.1-7% chromium and 0-3.5% nickel plus less than 5% other metals or the material contains 90-96% iron, 3-6% chromium and 0-3% nickel plus 0-5% other metals.
- a medical implant according to the present invention is characterized in that the implant is a vessel support having an essentially tubular basic component.
- Preferred shapes for an implant of the invention include a helix (coil), and umbrella, a stent, a wire network, a clip or a plug.
- a medical implant according to the present invention is characterized in that the implant has an endoluminal supporting function in hollow organs and/or duct systems (e.g. ureters, bile ducts, urethra, uterus, bronchi).
- a medical implant according to the present invention is characterized in that the implant is an occlude useful in a system for occluding connections between cavities, vessels or duct systems, or the implant is a fastening or supporting device for temporarily fixing tissue implants or transplants.
- a medical implant of the invention includes an orthopaedic implant, for example, a screw, a nail, a wire, a plate or a part of a joint.
- a medical implant according to the present invention includes those where the thickness of the material is chosen as a function of the composition of the material so that the degradation or corrosion process in vivo is essentially complete within the time period, or region, of 5 days up to 6 months, in particular between 2 weeks and 8 weeks.
- the thickness of the material is chosen as a function of the composition of the material so that the degradation or corrosion process in vivo is essentially complete within the region of 6 months up to 10 years, in particular between 1 year and 5 years.
- the metallic material composition, thickness and other dimensions are chosen so that the degradation or corrosion process in vivo initially leads to mechanical instability of the implant shape before the degradation process of the metallic material is essentially complete.
Abstract
The invention relates to a medical implant made of a metallic material. After fulfilling its temporary support function, the implant is degraded by corrosion at a predetermined rate. Negative long-term effects are thus avoided.
Description
- This application is a continuation of application Ser. No. 09/269,084, filed on Mar. 18, 1999, which is a National Stage filing of International Application PCT/EP98/04415, filed Jul. 17, 1998, claiming priority to German Application No. DE 197 31 021.4 filed Jul. 18, 1997, entitled “METALLIC IMPLANT WHICH IS DEGRADABLE IN VIVO”. The subject application claims priority to PCT/EP98/04415 and to German Application No. DE 197 31 021.4 and incorporates all by reference herein, in their entirety.
- 1. Field of the Invention
- The present invention relates to implants made of metallic materials for use in the human or animal body.
- 2. Description of Related Art
- Implants of this type hare in principle been known for a long time. The first implants were developed for orthopaedic purposes, for example screws and nails for fixing bone fractures. These initially consisted of relatively simple iron alloys which were prone to corrosion under in vivo conditions. The corrosion led to metals being released as ions in the direct vicinity of the bone providing an unwanted stimulus for the growth of bone tissue. The bone grew more than is actually wanted and necessary. This led to damage to healthy bone material.
- For this reason, attempts have been made to fabricate metallic implants in principle from materials with maximum corrosion resistance. Currently in use in this connection are mainly corrosion-resistant stainless steels, tantalum and titanium. These implants persist as foreign bodies after the implantation and they are recognized as such by the body. They can be removed only by a second operation.
- In addition, metallic implants are known in the specialty of vascular surgery and cardiology, angiology and radiology. These implants comprise, for example, endoluminal and vessel supports (stents) for treating lesions. These supports are used, for example, for widening and maintaining the lumen of narrowed vessels by keeping the vessel lumen at an appropriately optimal internal diameter using a balloon catheter (balloon expandable) or self-expanding from the vessel lumen outwards. The implant is intrinsically necessary only until the diseased vessel is able permanently to maintain the necessary diameter under its own power due to biological repair processes. This is generally the case about 4 weeks after implantation.
- However, some disadvantages are associated with permanent retention of a metallic implant. As a foreign body, the implant leads to local and possibly also systemic reactions. In addition, the self-regulation of the affected vessel segment is impeded. The continual (pulsatile) stress on the metal may lead to fatigue fractures, which in the case of large-lumen implants (e.g. occlusion systems such as umbrellas) may lead to new medical problems. About 20% of vessel supports in smaller lumina (2.5-6 mm) cause renewed stenosis (called in-stent stenosis) which, given the large number of implants, accumulates to an additional medical and economic burden. In some vessel regions (e.g. extracranial vessels, leg arteries) the metallic structure may be permanently deformed by forces acting from outside, resulting in renewed vessel obstruction or induced vessel occlusion. Every permanent implant is additionally associated with problems in particular for younger patients because retention for decades is unavoidable.
- The only completely biodegradable implants disclosed to date, for example in DE 2502884 C2, are made of synthetic materials. There is disclosure therein of coating an orthopaedic implant with polymethylmethacrylate which is biodegradable. Other synthetic materials comprise polylactide and polyglycolic esters. In addition, EP 0006544 B1 discloses a biodegradable ceramic material based on calcium phosphate, which is likewise used for coating metallic implants.
- Finally, WO 81/02668 discloses an orthopaedic implant which comprises a corrosion-resistant metallic basic component and a biodegradable intermediate metallic layer for the bone contact region. This intermediate layer forms together with the basic component an electrochemical cell and generates an electrical voltage which promotes bone growth. At the same time, the surface layer which may, for example, consist of silver alloys is degraded. This leads to the desired effect, that bone growth is beneficially influenced for as long as necessary and then, after complete degradation of the surface coating, the electrical stimulus declines.
- Previously disclosed biodegradable polymer-based substances are used in vascular surgery. Their mechanical properties on the one hand and the subsequent foreign-body reaction during the biodegradation on the other hand lead to them is being unsuitable on their own as material for implantation. Metallic materials/alloys have favourable mechanical properties (elasticity, deformability, stability) while being less bulky, which is an important precondition for administration through thin-lumen guide systems in the transcutaneous procedure.
- It is therefore an object of the present invention to provide implants made of biodegradable material having at the same time advantageous mechanical properties.
- This object is achieved by a medical implant made of metallic material, characterized in that the material is degradable in vivo through corrosion.
- Because the medical implant is fabricated from a metallic material which is degradable in vivo through corrosion, in the first place the mechanical advantages of metallic materials are present. The corrosive degradation of the implant within a time scale which can be set by the choice of material prevents, on the other hand, the adverse long-term effects of the metallic foreign body occurring. It is moreover biologically advantageous if the material is pure iron, where appropriate with a content of up to 7% carbon or an alloy or a sintered metal, the main constituent of which is selected from the group of alkali metals, of alkaline earth metals, iron, zinc or aluminium. Magnesium or iron is currently preferred as main constituent.
- The biological, mechanical and chemical properties of the materials can be beneficially affected if a subsidiary constituent is provided in the form of manganese, cobalt, nickel, chromium, copper, cadmium, leads tin, thorium, zirconium, silver, gold, palladium, platinum, rhenium, silicon, calcium, lithium, aluminium, zinc, iron, carbon or sulphur. The material preferred overall at present is either an alloy of magnesium with a content of up to 40% lithium plus addition of iron, or an iron alloy with a small content of aluminium, magnesium, nickel and/or zinc.
- Corrosion which is particularly satisfactory at the start of the degradation period is afforded by an alloy or a sintered metal made of approximately equal parts of zinc and irons.
- Advantageous decomposition times have furthermore been afforded by materials with magnesium as main constituent and either
- 0-40% lithium, 0-5% iron and less than 5% other metals or rare earths;
- 2-5% aluminium, 0-12% lithium and 1-4% rare earths, in particular cerium, lanthanum, neodymium and/or praseodymium,
- 6-12% lithium, 2% aluminium and 1% rare earths,
- 0-8% lithium, 2-4% aluminium and 1-2% rare earths,
- 8.5-9.5% aluminium, 0.15%-0.4% manganese, 0.45-0.9% zinc
- 4.5-5.3% aluminium, 0.28%-0.5% manganese or
- 30-40% lithium and 0-5% other metals and/or rare earths.
- Magnesium alloys of these types are available, for example, under the names AZ91D, AM50A and AE42.
- The design of the medical implant has several basic variants. The basic component provided for a vessel support is a tubular structure with additional processing. Advantageous occlusion systems (e.g. ductus arteriosus, congenital and acquired septal defects, arteriovenous shunt connections) are passively and/or actively unfoldable umbrella forms, helices or complex components. The invention is also applicable to occluders as systems for occluding connections between cavities, vessels or duct systems.
- It is additionally advantageous to provide the implant as fastening or supporting device for temporarily fixing tissue parts in the form of implants or transplants.
- To adjust the rate of corrosion of the material, it is advantageous if the thickness of the material is chosen as a function of the composition of the materials so that the degradation or corrosion process in vivo is essentially complete in between 5 days and 6 months, in particular between 2 weeks and 8 weeks.
- This results in the fixing device, which is no longer necessary, disappearing after the tissue implant has taken.
- Finally, it is advantageous if the implant is designed as orthopaedic implant, as implant for dentistry, for surgery to the upper abdomen or for accident surgery, in particular for treating the human body, in which case the alloy must be chosen so that bone growth is not adversely or excessively influenced. Orthopaedic implants according to the invention in the form of nails, screws or plates can be designed to degrade after the treated bone fracture has set and not require removal in a second operation.
- Various exemplary embodiments of the present invention are indicated below.
- A stent according to the invention is fabricated from a tubular basic component of the metallic material and subsequent processing. The mechanical structure of stents of this type is known, for example, from EP 0221570 B1, in which case the material is, however, a corrosion-resistant stainless steel.
- In this example of the stent according to the invention, the material is either an alloy having magnesium as main constituent and, where appropriate, the subsidiary constituents lithium, iron, zinc and traces of nickel, or an alloy having iron as main constituent and the subsidiary constituents chromium and nickel plus, where appropriate, traces of other additions. The percentage composition of the magnesium alloy should be approximately in the region of 50-98% magnesium, 0-40% lithium, 0-5% iron and less than 5% other metals, and that of the iron alloy approximately in the region of 88-99% iron, 0.5-7% chromium and 0.5-3.5% nickel plus less than 5% other metals. The wall thickness of the stent struts should be between 50 and 100 mm after the processing.
- In practice, the stent according to the invention will be inserted in a manner known per se using a balloon catheter into a pathologically narrowed blood vessel and there dilated or released as self-expanding stent, in which case it keeps the blood vessel at the required diameter. A restenosis remaining without stent implantation (recoil) and/or a tissue tear induced by the dilatation are effectively treated. Within 2-4 weeks the stent is covered by intimal tissue and initially retains its supporting function. The blood vessel acquires a new intrinsic stability through tissue growth as a result of its own repair processes in the region of the implanted stent. The vessel lumen is stabilized at an optimal level. The choice of the alloy material together with the chosen wall thickness result, on the other hand, in the stent gradually being degraded in the wall of the blood vessel and being present only in traces after 4-12 weeks. The disadvantages of a permanent implant are decreased or eliminated by the present invention. Such disadvantages include local and possibly systemic reactions, impedance of the self-regulation of the affected vessel segment, stress on the metal due to pulsations leading to fatigue fractures and, in the case of large-lumen implants including occlusion systems such as umbrellas, may lead to new medical problems.
- An occlusion system (umbrella) according to the invention is fabricated from a metallic skeleton to which a plastic umbrella is affixed. Umbrellas of this type are known, for example made of the alloy MP35N or Nitinol. Occlusion Systems of this type are used to occlude defects in septa of the heart. The wall thickness of the metallic framework is about 500 mm. In practice, the umbrella is folded up in a manner known per se and released in the defect which is to be occluded. Within 3-4 weeks, the umbrella is covered by endogenous tissue and acquires a new intrinsic stability thorough this tissue growth. The choice of the alloy material together with the tissue wall thickness results in the metallic framework being degraded within 4 weeks to a few months and being present only in traces after one year. The plastic content of the umbrella remains, which is not critical because of the flexibility of the material. The degradation of the metallic portion has the advantage by comparison with known umbrellas that, even if there are unpredicted stresses, e.g. associated with traffic accidents, there is no longer a risk of vessel walls being pierced. Moreover the advantage according to the invention is achieved even if the degradation results initially in mechanical instability of the framework.
- A helix (coil) according to the invention is fabricated from a metallic material wound helically, and the helix is prefixed. The diameter of the initial winding is 0.1-1 mm depending on the vessel to be occluded. Helices (coils) of this type are known, for example made of Nitinol, platinum alloys or tungsten alloys.
- In the present embodiment according to the invention, the material is an alloy with iron as main constituent and with subsidiary constituents nickel and/or chromium and traces of magnesium and zinc.
- In practice, the occluding helix (coil) is inserted in the extended state in a cardiac catheter in a manner known per se and is advanced through the latter as far as the vessel to be occluded. When the helix is released from the cardiac catheter it resumes its previous shape and occludes, through its lumen and its thrombogenicity, which can be increased by Dacron or other fibres, the vessel to be occluded. After the vessel has thrombosed and connective tissue has grown in, the occlusion mechanism acquires a new intrinsic stability. The administered helix is gradually degraded so that only traces of the implanted material are still present after about one year.
- The exemplary embodiments mentioned above can be fabricated both with use of magnesium alloys and with use of iron alloys. The materials are not known to have toxic effects at the concentrations to be expected.
- Magnesium alloys have the advantage that it is possible to select very accurately the degradation rate to be expected in vivo by a suitable choice of the other alloy constituents. In addition, magnesium is physiologically very well tolerated. Iron alloys are advantageous in terms of the mechanical stability, which is manifested by the small wall thicknesses possible for the implants. The alloy material can therefore be selected depending on the case for which it is used.
- In one aspect, the present invention provides medical implants which are made of a metallic material, characterized in that the material is degradable in vivo through corrosion. Metallic materials from which implants of the invention can be made are characterized in that the primary material is pure iron or an alloy whose main constituent is selected from the group comprising the following: alkali metals, alkaline earth metals, iron, zinc, aluminium. In a further aspect, the primary metallic material from which implants of the invention can be made is further characterized in that the material contains magnesium, iron, or zinc as main constituent. In one preferred embodiment, a medical implant according to the invention is characterized in that the metallic material contains iron and 0.5 to 7% carbon. In another aspect, a medical implant according to the invention is characterized in that the metallic material contains iron and zinc in approximately the same concentration.
- In an additional aspect, a medical implant according to the invention is characterized in that the metallic material contains as subsidiary constituents one or more elements from the group comprising the following: Mn, Co, Ni, Cr, Cu, Cd, Pb, Sn, Th, Zr, Ag, Au, Pd, Pt, Re, Si, Ca, Li, Al, Zn, Fe, C, S. In some preferred embodiments, the metallic material contains 50-98% magnesium, 0-40% lithium, 0-5% iron and less than 5% other metals or rare earths. In other preferred embodiments, the metallic material contains 79-97% magnesium, 2-5% aluminium, 0-12% lithium and 1-4% rare earths, in particular cerium, lanthanum, neodymium and/or praseodymium. In yet other preferred embodiments, the alloy is characterized in that the material contains 85-91% magnesium, 6-12% lithium, 2% aluminium and 1% rare earths. In yet other embodiments, the metallic material contains 86-97% magnesium, 0-8% lithium, 2%-4% aluminium and 1-2% rare earths.
- In additional preferred embodiments, the metallic material contains 8.5-9.5% aluminium, 0.15%-0.4% manganese, 0.45-0.9% zinc and the remainder to 100% magnesium. In still other preferred embodiments, the metallic material of a medical implant according to the invention is characterized in that the material contains 4.5-5.3% aluminium, 0.28%-0.5% manganese and the remainder to 100% magnesium. In additional preferred embodiments, the metallic material is characterized in that the material contains 55-65% magnesium, 30-40% lithium and 0-5% other metals and/or rare earths. In yet additional preferred embodiments, the metallic material is characterized in that the material contains 88-99.8% iron, 0.1-7% chromium and 0-3.5% nickel plus less than 5% other metals or the material contains 90-96% iron, 3-6% chromium and 0-3% nickel plus 0-5% other metals.
- In another key aspect, a medical implant according to the present invention is characterized in that the implant is a vessel support having an essentially tubular basic component. Preferred shapes for an implant of the invention include a helix (coil), and umbrella, a stent, a wire network, a clip or a plug. In an additional key aspect, a medical implant according to the present invention is characterized in that the implant has an endoluminal supporting function in hollow organs and/or duct systems (e.g. ureters, bile ducts, urethra, uterus, bronchi). In another significant aspect, a medical implant according to the present invention is characterized in that the implant is an occlude useful in a system for occluding connections between cavities, vessels or duct systems, or the implant is a fastening or supporting device for temporarily fixing tissue implants or transplants. In still other significant embodiments, a medical implant of the invention includes an orthopaedic implant, for example, a screw, a nail, a wire, a plate or a part of a joint.
- As a further advantage, a medical implant according to the present invention includes those where the thickness of the material is chosen as a function of the composition of the material so that the degradation or corrosion process in vivo is essentially complete within the time period, or region, of 5 days up to 6 months, in particular between 2 weeks and 8 weeks. As another advantageous aspect, the thickness of the material is chosen as a function of the composition of the material so that the degradation or corrosion process in vivo is essentially complete within the region of 6 months up to 10 years, in particular between 1 year and 5 years. Preferably, the metallic material composition, thickness and other dimensions are chosen so that the degradation or corrosion process in vivo initially leads to mechanical instability of the implant shape before the degradation process of the metallic material is essentially complete.
Claims (15)
1. A vessel support or stent for widening and maintaining the lumen of narrowed vessels, said vessel support or stent being made from a metallic material degradable in vivo through corrosion, wherein the vessel support or stent has a substantially hollow tubular base body, and wherein the material is an alloy, the main constituent of which is magnesium.
2. The vessel support or stent according to claim 1 , wherein the material contains 79-97% of magnesium, 2-5% of aluminium, 0-12% of lithium and 1-4% of rare earths.
3. The vessel support or stent according to claim 1 , wherein the material contains 85-91% of magnesium, 2% of aluminium, 6-12% of lithium and 1% of rare earths.
4. The vessel support or stent according to claim 1 , wherein the material contains 86-97% of magnesium, 2-4% of aluminium, 0-8% of lithium and 1-2% of rare earths.
5. The vessel support or stent according to claim 1 , wherein the thickness of the material is chosen in dependence on the composition of the material such that the process of degradation or corrosion in vivo is substantially completed in the range of from 5 days up to 6 months after implantation.
6. The vessel support or stent according to claim 1 , wherein the thickness of the material is chosen in dependence on the composition of the material such that the process of degradation or corrosion in vivo is substantially completed in the range of from 6 months up to 10 years after implantation.
7. The vessel support or stent according to claim 1 , wherein the material contains, as secondary constituent, one or more elements from the group consisting of: Mn, Co, Ni, Cr, Cu, Pb, Sn, Th, Zr, Ag, Au, Pd, Pt, Re, Si, Ca, Li, Al, Zn, Fe, C, S.
8. The vessel support or stent according to claim 2 , wherein the rare earths are selected from the group consisting of cerium, lanthanum, neodymium and praseodymium.
9. The vessel support or stent according to claim 1 , wherein the thickness of the material is between approximately 50 μm and approximately 100 μm.
10. The vessel support or stent according to claim 1 , wherein the thickness of the material is chosen in dependence on the composition of the material such that the degradation or corrosion process in vivo is substantially completed between 2 weeks and 8 weeks after implantation.
11. The vessel support or stent according to claim 1 , wherein the thickness of the material is chosen in dependence on the composition of the material such that the process of degradation or corrosion in vivo is substantially completed between 1 year and 5 years after implantation.
12. The vessel support or stent according to claim 1 , wherein the material contains 50-89% magnesium, 0-40% lithium, 0-5% iron, and less than 5% other metals or rare earths.
13. A vessel support or stent for widening and maintaining the lumen of narrowed vessels, said vessel support or stent being made from a metallic material degradable in vivo through corrosion, wherein the vessel support or stent has a substantially hollow tubular base body, and wherein the material is an alloy containing 79-97% magnesium, 2-5% aluminium, 0-12% lithium and 1-4% rare earths.
14. A vessel support or stent for widening and maintaining the lumen of narrowed vessels, said vessel support or stent being made from a metallic material degradable in vivo through corrosion, wherein the vessel support or stent has a substantially hollow tubular base body, and wherein the material is an alloy containing 79-97% magnesium, 2-5% aluminium, 0-12% lithium and 1-4% rare earths, and wherein the thickness of the material is chosen in dependence on the composition of the material such that the degradation or corrosion process in vivo is substantially completed between 5 days and 6 months after implantation.
15. A vessel support or stent for widening and maintaining the lumen of narrowed vessels, said vessel support or stent being made from a metallic material degradable in vivo through corrosion, wherein the vessel support or stent has a substantially hollow tubular base body, and wherein the material is an alloy containing 79-97% magnesium, 2-5% aluminium, 0-12% lithium and 1-4% rare earths and wherein the thickness of the material is chosen in dependence on the composition of the material such that the degradation or corrosion process in vivo is substantially completed between 2 weeks and 8 weeks after implantation.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/897,967 US20110251669A1 (en) | 1997-07-18 | 2010-10-05 | Metallic implant which is degradable in vivo |
US13/211,921 US8771751B2 (en) | 1997-07-18 | 2011-08-17 | Metallic implant which is degradable in vivo |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19731021A DE19731021A1 (en) | 1997-07-18 | 1997-07-18 | In vivo degradable metallic implant |
DE19731021.4 | 1997-07-18 | ||
PCT/EP1998/004415 WO1999003515A2 (en) | 1997-07-18 | 1998-07-17 | Metallic implant which is degradable in vivo |
US09/269,084 US7879367B2 (en) | 1997-07-18 | 1998-07-17 | Metallic implant which is degradable in vivo |
US12/897,967 US20110251669A1 (en) | 1997-07-18 | 2010-10-05 | Metallic implant which is degradable in vivo |
Related Parent Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1998/004415 Continuation WO1999003515A2 (en) | 1997-07-18 | 1998-07-17 | Metallic implant which is degradable in vivo |
US09/269,084 Continuation US7879367B2 (en) | 1997-07-18 | 1998-07-17 | Metallic implant which is degradable in vivo |
US09269084 Continuation | 1998-07-17 | ||
PCT/EP2008/004415 Continuation WO2008148521A1 (en) | 2007-06-04 | 2008-06-03 | Device for paying a prescribed billed amount and method for accepting value documents and dispensing value documents stored in a storage device |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/211,921 Continuation US8771751B2 (en) | 1997-07-18 | 2011-08-17 | Metallic implant which is degradable in vivo |
Publications (1)
Publication Number | Publication Date |
---|---|
US20110251669A1 true US20110251669A1 (en) | 2011-10-13 |
Family
ID=7836229
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/269,084 Expired - Fee Related US7879367B2 (en) | 1997-07-18 | 1998-07-17 | Metallic implant which is degradable in vivo |
US12/897,967 Abandoned US20110251669A1 (en) | 1997-07-18 | 2010-10-05 | Metallic implant which is degradable in vivo |
US13/211,921 Expired - Fee Related US8771751B2 (en) | 1997-07-18 | 2011-08-17 | Metallic implant which is degradable in vivo |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/269,084 Expired - Fee Related US7879367B2 (en) | 1997-07-18 | 1998-07-17 | Metallic implant which is degradable in vivo |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/211,921 Expired - Fee Related US8771751B2 (en) | 1997-07-18 | 2011-08-17 | Metallic implant which is degradable in vivo |
Country Status (11)
Country | Link |
---|---|
US (3) | US7879367B2 (en) |
EP (3) | EP1552856B1 (en) |
JP (3) | JP5352776B2 (en) |
AT (2) | ATE236667T1 (en) |
AU (1) | AU9154198A (en) |
DE (3) | DE19731021A1 (en) |
DK (1) | DK1270023T3 (en) |
ES (2) | ES2200368T3 (en) |
IL (3) | IL129065A0 (en) |
PT (1) | PT1270023E (en) |
WO (1) | WO1999003515A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10960110B2 (en) * | 2018-08-21 | 2021-03-30 | Jian Xie | Iron-based biodegradable metals for implantable medical devices |
Families Citing this family (602)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10028851B2 (en) | 1997-04-15 | 2018-07-24 | Advanced Cardiovascular Systems, Inc. | Coatings for controlling erosion of a substrate of an implantable medical device |
US8172897B2 (en) | 1997-04-15 | 2012-05-08 | Advanced Cardiovascular Systems, Inc. | Polymer and metal composite implantable medical devices |
US6240616B1 (en) | 1997-04-15 | 2001-06-05 | Advanced Cardiovascular Systems, Inc. | Method of manufacturing a medicated porous metal prosthesis |
US6776792B1 (en) * | 1997-04-24 | 2004-08-17 | Advanced Cardiovascular Systems Inc. | Coated endovascular stent |
DE19731021A1 (en) * | 1997-07-18 | 1999-01-21 | Meyer Joerg | In vivo degradable metallic implant |
US8668737B2 (en) | 1997-10-10 | 2014-03-11 | Senorx, Inc. | Tissue marking implant |
US7637948B2 (en) | 1997-10-10 | 2009-12-29 | Senorx, Inc. | Tissue marking implant |
US7713297B2 (en) * | 1998-04-11 | 2010-05-11 | Boston Scientific Scimed, Inc. | Drug-releasing stent with ceramic-containing layer |
DE59913189D1 (en) | 1998-06-25 | 2006-05-04 | Biotronik Ag | Implantable, bioabsorbable vessel wall support, in particular coronary stent |
GB9815158D0 (en) * | 1998-07-13 | 1998-09-09 | William Harvey Research Limite | Stents |
US7314477B1 (en) | 1998-09-25 | 2008-01-01 | C.R. Bard Inc. | Removable embolus blood clot filter and filter delivery unit |
US20090216118A1 (en) | 2007-07-26 | 2009-08-27 | Senorx, Inc. | Polysaccharide markers |
US6862470B2 (en) | 1999-02-02 | 2005-03-01 | Senorx, Inc. | Cavity-filling biopsy site markers |
US7983734B2 (en) | 2003-05-23 | 2011-07-19 | Senorx, Inc. | Fibrous marker and intracorporeal delivery thereof |
US8498693B2 (en) | 1999-02-02 | 2013-07-30 | Senorx, Inc. | Intracorporeal marker and marker delivery device |
US9820824B2 (en) | 1999-02-02 | 2017-11-21 | Senorx, Inc. | Deployment of polysaccharide markers for treating a site within a patent |
US7651505B2 (en) | 2002-06-17 | 2010-01-26 | Senorx, Inc. | Plugged tip delivery for marker placement |
US8361082B2 (en) | 1999-02-02 | 2013-01-29 | Senorx, Inc. | Marker delivery device with releasable plug |
US6725083B1 (en) | 1999-02-02 | 2004-04-20 | Senorx, Inc. | Tissue site markers for in VIVO imaging |
US6575991B1 (en) | 1999-06-17 | 2003-06-10 | Inrad, Inc. | Apparatus for the percutaneous marking of a lesion |
US6790228B2 (en) * | 1999-12-23 | 2004-09-14 | Advanced Cardiovascular Systems, Inc. | Coating for implantable devices and a method of forming the same |
DE19945049A1 (en) * | 1999-09-20 | 2001-03-22 | Meyer Joerg | Medicinal implant formed from alloy of tungsten, rhenium, osmium or molydenum having pH dependent corrosion rate, useful e.g. for controlled drug release |
CA2659518A1 (en) | 2000-11-20 | 2002-05-30 | Senorx, Inc. | Tissue site markers for in vivo imaging |
DE10064596A1 (en) | 2000-12-18 | 2002-06-20 | Biotronik Mess & Therapieg | Application of a marker element to an implant, especially a stent, comprises introducing a solidifiable material into a recess and solidifying the material in the recess |
DK1370306T3 (en) | 2001-01-05 | 2005-11-07 | Jacqueline Yvonne Hausdorf | In corrosion, degradable metallic medical implants |
DE10118603A1 (en) * | 2001-04-12 | 2002-10-17 | Gerd Hausdorf | Biodegradable implant, e.g. for sealing defects in blood vessels or the heart, comprises a corrosively degradable tungsten, iron or magnesium alloy support structure bonded with another material |
DE10128100A1 (en) * | 2001-06-11 | 2002-12-19 | Hannover Med Hochschule | Medical implant used for humans and animals is made from magnesium alloy containing additions of rare earth metals and lithium |
AU2002345328A1 (en) | 2001-06-27 | 2003-03-03 | Remon Medical Technologies Ltd. | Method and device for electrochemical formation of therapeutic species in vivo |
US6565659B1 (en) * | 2001-06-28 | 2003-05-20 | Advanced Cardiovascular Systems, Inc. | Stent mounting assembly and a method of using the same to coat a stent |
US7989018B2 (en) | 2001-09-17 | 2011-08-02 | Advanced Cardiovascular Systems, Inc. | Fluid treatment of a polymeric coating on an implantable medical device |
US7285304B1 (en) | 2003-06-25 | 2007-10-23 | Advanced Cardiovascular Systems, Inc. | Fluid treatment of a polymeric coating on an implantable medical device |
US6863683B2 (en) | 2001-09-19 | 2005-03-08 | Abbott Laboratoris Vascular Entities Limited | Cold-molding process for loading a stent onto a stent delivery system |
DE10153542B4 (en) * | 2001-10-30 | 2006-11-23 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Method for making adapters for blood vessels |
DE10153541B4 (en) * | 2001-10-30 | 2008-05-08 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Blood vessel adapter |
DE10163106A1 (en) * | 2001-12-24 | 2003-07-10 | Univ Hannover | Medical implants, prostheses, prosthesis parts, medical instruments, devices and aids made of a halide-modified magnesium material |
DE10164024A1 (en) * | 2001-12-28 | 2003-07-17 | Univ Hannover | Method and device for jet cutting tissue |
WO2003063733A1 (en) * | 2002-01-31 | 2003-08-07 | Radi Medical Systems Ab | Stent |
US9204956B2 (en) | 2002-02-20 | 2015-12-08 | C. R. Bard, Inc. | IVC filter with translating hooks |
DE10207161B4 (en) * | 2002-02-20 | 2004-12-30 | Universität Hannover | Process for the production of implants |
DE10243136A1 (en) | 2002-09-17 | 2004-05-19 | Campus Medizin & Technik Gmbh | Stent for implantation in or around a hollow organ |
US20060271168A1 (en) * | 2002-10-30 | 2006-11-30 | Klaus Kleine | Degradable medical device |
US8524148B2 (en) * | 2002-11-07 | 2013-09-03 | Abbott Laboratories | Method of integrating therapeutic agent into a bioerodible medical device |
DE10253634A1 (en) * | 2002-11-13 | 2004-05-27 | Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin | endoprosthesis |
DE10253633B4 (en) | 2002-11-13 | 2011-08-11 | BIOTRONIK GmbH & Co. KG, 12359 | supporting structure |
US20040098090A1 (en) * | 2002-11-14 | 2004-05-20 | Williams Michael S. | Polymeric endoprosthesis and method of manufacture |
US20060036158A1 (en) * | 2003-11-17 | 2006-02-16 | Inrad, Inc. | Self-contained, self-piercing, side-expelling marking apparatus |
DE10311729A1 (en) * | 2003-03-18 | 2004-09-30 | Schultheiss, Heinz-Peter, Prof. Dr. | Endovascular implant with an at least sectionally active coating of ratjadon and / or a ratjadon derivative |
US9060770B2 (en) | 2003-05-20 | 2015-06-23 | Ethicon Endo-Surgery, Inc. | Robotically-driven surgical instrument with E-beam driver |
DE10323628A1 (en) | 2003-05-20 | 2004-12-30 | Biotronik Ag | Stents made of a material with low elongation at break |
US20070084897A1 (en) | 2003-05-20 | 2007-04-19 | Shelton Frederick E Iv | Articulating surgical stapling instrument incorporating a two-piece e-beam firing mechanism |
US7877133B2 (en) | 2003-05-23 | 2011-01-25 | Senorx, Inc. | Marker or filler forming fluid |
CA2527975C (en) * | 2003-06-13 | 2011-08-09 | Mnemoscience Gmbh | Biodegradable stents comprising a shape memory polymeric material |
US20060052824A1 (en) * | 2003-06-16 | 2006-03-09 | Ransick Mark H | Surgical implant |
US7905902B2 (en) * | 2003-06-16 | 2011-03-15 | Ethicon Endo-Surgery, Inc. | Surgical implant with preferential corrosion zone |
US20060052825A1 (en) * | 2003-06-16 | 2006-03-09 | Ransick Mark H | Surgical implant alloy |
US7488343B2 (en) * | 2003-09-16 | 2009-02-10 | Boston Scientific Scimed, Inc. | Medical devices |
EP1667748B1 (en) * | 2003-09-28 | 2011-05-25 | Guido Schnyder | Biodegradable and/or bioabsorbable member for vascular sealing |
US7198675B2 (en) | 2003-09-30 | 2007-04-03 | Advanced Cardiovascular Systems | Stent mandrel fixture and method for selectively coating surfaces of a stent |
US20050273002A1 (en) | 2004-06-04 | 2005-12-08 | Goosen Ryan L | Multi-mode imaging marker |
DE10361941A1 (en) * | 2003-12-24 | 2005-07-28 | Restate Patent Ag | Coating for the outer surface of a medical implant, especially a stent or electrode, comprises magnesium, a magnesium alloy or a magnesium salt |
DE10361942A1 (en) * | 2003-12-24 | 2005-07-21 | Restate Patent Ag | Radioopaque marker for medical implants |
CA2552405C (en) * | 2004-02-06 | 2011-12-13 | Biotronik Vi Patent Ag | Implant for releasing an active substance into a vessel through which a body medium flows |
DE102004029611A1 (en) | 2004-02-06 | 2005-08-25 | Restate Patent Ag | Implant for e.g. releasing active substances into a vessel through which body fluids flow, comprises a base consisting of a biodegradable material as the carrier of the active substances |
US8137397B2 (en) * | 2004-02-26 | 2012-03-20 | Boston Scientific Scimed, Inc. | Medical devices |
US20050214339A1 (en) | 2004-03-29 | 2005-09-29 | Yiwen Tang | Biologically degradable compositions for medical applications |
US20050288481A1 (en) * | 2004-04-30 | 2005-12-29 | Desnoyer Jessica R | Design of poly(ester amides) for the control of agent-release from polymeric compositions |
CA2567138C (en) * | 2004-05-20 | 2013-07-30 | Boston Scientific Limited | Endoprostheses and methods of making the same |
US7758892B1 (en) * | 2004-05-20 | 2010-07-20 | Boston Scientific Scimed, Inc. | Medical devices having multiple layers |
US20060100696A1 (en) * | 2004-11-10 | 2006-05-11 | Atanasoska Ljiljana L | Medical devices and methods of making the same |
DE102004026104A1 (en) * | 2004-05-25 | 2005-12-15 | Restate Patent Ag | Implant to the vessel ligature |
US10316616B2 (en) | 2004-05-28 | 2019-06-11 | Schlumberger Technology Corporation | Dissolvable bridge plug |
US8211247B2 (en) | 2006-02-09 | 2012-07-03 | Schlumberger Technology Corporation | Degradable compositions, apparatus comprising same, and method of use |
US8568469B1 (en) | 2004-06-28 | 2013-10-29 | Advanced Cardiovascular Systems, Inc. | Stent locking element and a method of securing a stent on a delivery system |
US8241554B1 (en) | 2004-06-29 | 2012-08-14 | Advanced Cardiovascular Systems, Inc. | Method of forming a stent pattern on a tube |
DE102004035905A1 (en) * | 2004-07-20 | 2006-02-16 | Biotronik Vi Patent Ag | Magnesium-containing wound dressing material |
DE102004036954A1 (en) * | 2004-07-21 | 2006-03-16 | Ossacur Ag | Implantable body for spinal fusion |
US7971333B2 (en) | 2006-05-30 | 2011-07-05 | Advanced Cardiovascular Systems, Inc. | Manufacturing process for polymetric stents |
US8747878B2 (en) | 2006-04-28 | 2014-06-10 | Advanced Cardiovascular Systems, Inc. | Method of fabricating an implantable medical device by controlling crystalline structure |
US8747879B2 (en) | 2006-04-28 | 2014-06-10 | Advanced Cardiovascular Systems, Inc. | Method of fabricating an implantable medical device to reduce chance of late inflammatory response |
US20060020330A1 (en) * | 2004-07-26 | 2006-01-26 | Bin Huang | Method of fabricating an implantable medical device with biaxially oriented polymers |
US8778256B1 (en) | 2004-09-30 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Deformation of a polymer tube in the fabrication of a medical article |
US7731890B2 (en) | 2006-06-15 | 2010-06-08 | Advanced Cardiovascular Systems, Inc. | Methods of fabricating stents with enhanced fracture toughness |
US11896225B2 (en) | 2004-07-28 | 2024-02-13 | Cilag Gmbh International | Staple cartridge comprising a pan |
US7704267B2 (en) | 2004-08-04 | 2010-04-27 | C. R. Bard, Inc. | Non-entangling vena cava filter |
US20060041102A1 (en) * | 2004-08-23 | 2006-02-23 | Advanced Cardiovascular Systems, Inc. | Implantable devices comprising biologically absorbable polymers having constant rate of degradation and methods for fabricating the same |
US9283099B2 (en) | 2004-08-25 | 2016-03-15 | Advanced Cardiovascular Systems, Inc. | Stent-catheter assembly with a releasable connection for stent retention |
JP2006061381A (en) * | 2004-08-26 | 2006-03-09 | Terumo Corp | Intravascular implant |
US11207457B2 (en) * | 2004-08-27 | 2021-12-28 | Edwards Lifesciences Corporation | Device and method for establishing an artificial arterio-venous fistula |
EP2169090B3 (en) | 2008-09-30 | 2014-06-25 | Biotronik VI Patent AG | Implant made of a biodegradable magnesium alloy |
DE102004043232A1 (en) | 2004-09-07 | 2006-03-09 | Biotronik Vi Patent Ag | Endoprosthesis made of magnesium alloy |
DE102004043231A1 (en) * | 2004-09-07 | 2006-03-09 | Biotronik Vi Patent Ag | Endoprosthesis made of magnesium alloy |
US9468704B2 (en) | 2004-09-07 | 2016-10-18 | Biotronik Vi Patent Ag | Implant made of a biodegradable magnesium alloy |
DE502005008226D1 (en) | 2004-09-07 | 2009-11-12 | Biotronik Vi Patent Ag | Endoprosthesis made of magnesium alloy |
DE102004044679A1 (en) * | 2004-09-09 | 2006-03-16 | Biotronik Vi Patent Ag | Implant with low radial strength |
US7229471B2 (en) * | 2004-09-10 | 2007-06-12 | Advanced Cardiovascular Systems, Inc. | Compositions containing fast-leaching plasticizers for improved performance of medical devices |
US20070055305A1 (en) * | 2004-09-23 | 2007-03-08 | Guido Schnyder | Biodegradable and/or bioabsorbable member for vascular sealing |
US7875233B2 (en) | 2004-09-30 | 2011-01-25 | Advanced Cardiovascular Systems, Inc. | Method of fabricating a biaxially oriented implantable medical device |
US8173062B1 (en) | 2004-09-30 | 2012-05-08 | Advanced Cardiovascular Systems, Inc. | Controlled deformation of a polymer tube in fabricating a medical article |
US8043553B1 (en) | 2004-09-30 | 2011-10-25 | Advanced Cardiovascular Systems, Inc. | Controlled deformation of a polymer tube with a restraining surface in fabricating a medical article |
US20070265354A1 (en) * | 2004-10-21 | 2007-11-15 | Canham Leigh T | Silicon Structure |
US8419656B2 (en) | 2004-11-22 | 2013-04-16 | Bard Peripheral Vascular, Inc. | Post decompression marker introducer system |
US20060122694A1 (en) * | 2004-12-03 | 2006-06-08 | Stinson Jonathan S | Medical devices and methods of making the same |
US20060127443A1 (en) * | 2004-12-09 | 2006-06-15 | Helmus Michael N | Medical devices having vapor deposited nanoporous coatings for controlled therapeutic agent delivery |
JP2006167078A (en) * | 2004-12-15 | 2006-06-29 | Terumo Corp | Medical implant |
US8029529B1 (en) | 2005-01-19 | 2011-10-04 | C. R. Bard, Inc. | Retrievable filter |
DE102005003188A1 (en) | 2005-01-20 | 2006-07-27 | Restate Patent Ag | Medical implant made of an amorphous or nanocrystalline alloy |
WO2006080381A1 (en) | 2005-01-28 | 2006-08-03 | Terumo Kabushiki Kaisha | Intravascular implant |
US20060173424A1 (en) * | 2005-02-01 | 2006-08-03 | Conlon Sean P | Surgically implantable injection port having an absorbable fastener |
US20060198869A1 (en) * | 2005-03-03 | 2006-09-07 | Icon Medical Corp. | Bioabsorable medical devices |
EP1855617A4 (en) * | 2005-03-11 | 2013-10-23 | Covidien Lp | Absorbable surgical fasteners |
US20060216431A1 (en) * | 2005-03-28 | 2006-09-28 | Kerrigan Cameron K | Electrostatic abluminal coating of a stent crimped on a balloon catheter |
US20060224226A1 (en) * | 2005-03-31 | 2006-10-05 | Bin Huang | In-vivo radial orientation of a polymeric implantable medical device |
WO2006108065A2 (en) | 2005-04-05 | 2006-10-12 | Elixir Medical Corporation | Degradable implantable medical devices |
US7381048B2 (en) | 2005-04-12 | 2008-06-03 | Advanced Cardiovascular Systems, Inc. | Stents with profiles for gripping a balloon catheter and molds for fabricating stents |
US10357328B2 (en) | 2005-04-20 | 2019-07-23 | Bard Peripheral Vascular, Inc. and Bard Shannon Limited | Marking device with retractable cannula |
CN100400114C (en) * | 2005-04-30 | 2008-07-09 | 中国科学院金属研究所 | Biomedicine implant material with controllable degrading rate and its application |
US8071155B2 (en) * | 2005-05-05 | 2011-12-06 | Boston Scientific Scimed, Inc. | Medical devices and methods of making the same |
JP5102201B2 (en) | 2005-05-12 | 2012-12-19 | シー・アール・バード・インコーポレーテッド | Removable embolic clot filter |
US7291166B2 (en) * | 2005-05-18 | 2007-11-06 | Advanced Cardiovascular Systems, Inc. | Polymeric stent patterns |
US20060276910A1 (en) * | 2005-06-01 | 2006-12-07 | Jan Weber | Endoprostheses |
US7622070B2 (en) * | 2005-06-20 | 2009-11-24 | Advanced Cardiovascular Systems, Inc. | Method of manufacturing an implantable polymeric medical device |
US20070038176A1 (en) * | 2005-07-05 | 2007-02-15 | Jan Weber | Medical devices with machined layers for controlled communications with underlying regions |
US20070025848A1 (en) * | 2005-07-29 | 2007-02-01 | Shawcross James P | Reduced noise diffuser for a motor-fan assembly |
US7658880B2 (en) | 2005-07-29 | 2010-02-09 | Advanced Cardiovascular Systems, Inc. | Polymeric stent polishing method and apparatus |
US7297758B2 (en) * | 2005-08-02 | 2007-11-20 | Advanced Cardiovascular Systems, Inc. | Method for extending shelf-life of constructs of semi-crystallizable polymers |
WO2007021340A1 (en) | 2005-08-09 | 2007-02-22 | C.R. Bard Inc | Embolus blood clot filter and delivery system |
US20070038290A1 (en) * | 2005-08-15 | 2007-02-15 | Bin Huang | Fiber reinforced composite stents |
US7476245B2 (en) * | 2005-08-16 | 2009-01-13 | Advanced Cardiovascular Systems, Inc. | Polymeric stent patterns |
US20070045255A1 (en) * | 2005-08-23 | 2007-03-01 | Klaus Kleine | Laser induced plasma machining with an optimized process gas |
US20070045252A1 (en) * | 2005-08-23 | 2007-03-01 | Klaus Kleine | Laser induced plasma machining with a process gas |
US9248034B2 (en) | 2005-08-23 | 2016-02-02 | Advanced Cardiovascular Systems, Inc. | Controlled disintegrating implantable medical devices |
US20090234384A1 (en) * | 2005-08-26 | 2009-09-17 | Hadba Ahmad R | Absorbable surgical materials |
US20070050009A1 (en) * | 2005-08-30 | 2007-03-01 | Aiden Flanagan | Bioabsorbable stent |
US11246590B2 (en) | 2005-08-31 | 2022-02-15 | Cilag Gmbh International | Staple cartridge including staple drivers having different unfired heights |
US7669746B2 (en) | 2005-08-31 | 2010-03-02 | Ethicon Endo-Surgery, Inc. | Staple cartridges for forming staples having differing formed staple heights |
US11484312B2 (en) | 2005-08-31 | 2022-11-01 | Cilag Gmbh International | Staple cartridge comprising a staple driver arrangement |
US7934630B2 (en) | 2005-08-31 | 2011-05-03 | Ethicon Endo-Surgery, Inc. | Staple cartridges for forming staples having differing formed staple heights |
US10159482B2 (en) | 2005-08-31 | 2018-12-25 | Ethicon Llc | Fastener cartridge assembly comprising a fixed anvil and different staple heights |
US8567494B2 (en) | 2005-08-31 | 2013-10-29 | Schlumberger Technology Corporation | Well operating elements comprising a soluble component and methods of use |
US8663308B2 (en) | 2005-09-19 | 2014-03-04 | Cook Medical Technologies Llc | Graft with bioabsorbable support frame |
US8052658B2 (en) | 2005-10-07 | 2011-11-08 | Bard Peripheral Vascular, Inc. | Drug-eluting tissue marker |
US20070106317A1 (en) | 2005-11-09 | 2007-05-10 | Shelton Frederick E Iv | Hydraulically and electrically actuated articulation joints for surgical instruments |
EP1959025B1 (en) * | 2005-11-16 | 2012-03-21 | National Institute for Materials Science | Magnesium-based biodegradable metal material |
CA2940038C (en) | 2005-11-18 | 2018-08-28 | C.R. Bard, Inc. | Vena cava filter with filament |
WO2007064731A2 (en) * | 2005-12-02 | 2007-06-07 | C.R. Bard, Inc. | Helical vena cava filter |
EP1957006A2 (en) * | 2005-12-07 | 2008-08-20 | C.R.Bard, Inc. | Vena cava filter with stent |
US7867547B2 (en) | 2005-12-19 | 2011-01-11 | Advanced Cardiovascular Systems, Inc. | Selectively coating luminal surfaces of stents |
CN100340308C (en) * | 2005-12-22 | 2007-10-03 | 上海交通大学 | Bio-absorbable Mg-Zn-Fe three-elements magnesium alloy material |
US20070151961A1 (en) * | 2006-01-03 | 2007-07-05 | Klaus Kleine | Fabrication of an implantable medical device with a modified laser beam |
US20070156230A1 (en) | 2006-01-04 | 2007-07-05 | Dugan Stephen R | Stents with radiopaque markers |
US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US7951185B1 (en) | 2006-01-06 | 2011-05-31 | Advanced Cardiovascular Systems, Inc. | Delivery of a stent at an elevated temperature |
PT1806161E (en) * | 2006-01-10 | 2009-06-08 | Acrostak Corp Bvi | Implant for treatment of the inner walls of resection cavities |
US8820603B2 (en) | 2006-01-31 | 2014-09-02 | Ethicon Endo-Surgery, Inc. | Accessing data stored in a memory of a surgical instrument |
US11793518B2 (en) | 2006-01-31 | 2023-10-24 | Cilag Gmbh International | Powered surgical instruments with firing system lockout arrangements |
US20110290856A1 (en) | 2006-01-31 | 2011-12-01 | Ethicon Endo-Surgery, Inc. | Robotically-controlled surgical instrument with force-feedback capabilities |
US20120292367A1 (en) | 2006-01-31 | 2012-11-22 | Ethicon Endo-Surgery, Inc. | Robotically-controlled end effector |
US8708213B2 (en) | 2006-01-31 | 2014-04-29 | Ethicon Endo-Surgery, Inc. | Surgical instrument having a feedback system |
US8186555B2 (en) | 2006-01-31 | 2012-05-29 | Ethicon Endo-Surgery, Inc. | Motor-driven surgical cutting and fastening instrument with mechanical closure system |
US7845537B2 (en) | 2006-01-31 | 2010-12-07 | Ethicon Endo-Surgery, Inc. | Surgical instrument having recording capabilities |
US20070179219A1 (en) * | 2006-01-31 | 2007-08-02 | Bin Huang | Method of fabricating an implantable medical device using gel extrusion and charge induced orientation |
US8089029B2 (en) * | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
US8770261B2 (en) | 2006-02-09 | 2014-07-08 | Schlumberger Technology Corporation | Methods of manufacturing degradable alloys and products made from degradable alloys |
US20070191931A1 (en) * | 2006-02-16 | 2007-08-16 | Jan Weber | Bioerodible endoprostheses and methods of making the same |
US9526814B2 (en) * | 2006-02-16 | 2016-12-27 | Boston Scientific Scimed, Inc. | Medical balloons and methods of making the same |
JPWO2007108450A1 (en) * | 2006-03-20 | 2009-08-06 | 独立行政法人物質・材料研究機構 | Degradation time control method for medical biodegradable device |
US20070224244A1 (en) * | 2006-03-22 | 2007-09-27 | Jan Weber | Corrosion resistant coatings for biodegradable metallic implants |
US20070224235A1 (en) * | 2006-03-24 | 2007-09-27 | Barron Tenney | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
US8187620B2 (en) * | 2006-03-27 | 2012-05-29 | Boston Scientific Scimed, Inc. | Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents |
US7964210B2 (en) | 2006-03-31 | 2011-06-21 | Abbott Cardiovascular Systems Inc. | Degradable polymeric implantable medical devices with a continuous phase and discrete phase |
US20070239253A1 (en) | 2006-04-06 | 2007-10-11 | Jagger Karl A | Oscillation assisted drug elution apparatus and method |
US8048150B2 (en) | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
US20070250155A1 (en) * | 2006-04-24 | 2007-10-25 | Advanced Cardiovascular Systems, Inc. | Bioabsorbable medical device |
US7955383B2 (en) * | 2006-04-25 | 2011-06-07 | Medtronics Vascular, Inc. | Laminated implantable medical device having a metallic coating |
US20070254012A1 (en) * | 2006-04-28 | 2007-11-01 | Ludwig Florian N | Controlled degradation and drug release in stents |
WO2007133366A2 (en) | 2006-05-02 | 2007-11-22 | C. R. Bard, Inc. | Vena cava filter formed from a sheet |
US8069814B2 (en) | 2006-05-04 | 2011-12-06 | Advanced Cardiovascular Systems, Inc. | Stent support devices |
US7691400B2 (en) * | 2006-05-05 | 2010-04-06 | Medtronic Vascular, Inc. | Medical device having coating with zeolite drug reservoirs |
US20070264303A1 (en) * | 2006-05-12 | 2007-11-15 | Liliana Atanasoska | Coating for medical devices comprising an inorganic or ceramic oxide and a therapeutic agent |
EP2040771A2 (en) * | 2006-05-16 | 2009-04-01 | Medtronic Vascular, Inc. | Bioabsorbable magnesium-reinforced polymer stents |
US7761968B2 (en) | 2006-05-25 | 2010-07-27 | Advanced Cardiovascular Systems, Inc. | Method of crimping a polymeric stent |
US7951194B2 (en) | 2006-05-26 | 2011-05-31 | Abbott Cardiovascular Sysetms Inc. | Bioabsorbable stent with radiopaque coating |
US20130325104A1 (en) | 2006-05-26 | 2013-12-05 | Abbott Cardiovascular Systems Inc. | Stents With Radiopaque Markers |
US8343530B2 (en) | 2006-05-30 | 2013-01-01 | Abbott Cardiovascular Systems Inc. | Polymer-and polymer blend-bioceramic composite implantable medical devices |
US7959940B2 (en) | 2006-05-30 | 2011-06-14 | Advanced Cardiovascular Systems, Inc. | Polymer-bioceramic composite implantable medical devices |
US7842737B2 (en) | 2006-09-29 | 2010-11-30 | Abbott Cardiovascular Systems Inc. | Polymer blend-bioceramic composite implantable medical devices |
US20070282434A1 (en) * | 2006-05-30 | 2007-12-06 | Yunbing Wang | Copolymer-bioceramic composite implantable medical devices |
US20070282432A1 (en) * | 2006-05-31 | 2007-12-06 | Stinson Jonathan S | Implantable medical endoprostheses |
US20080058916A1 (en) * | 2006-05-31 | 2008-03-06 | Bin Huang | Method of fabricating polymeric self-expandable stent |
US8486135B2 (en) | 2006-06-01 | 2013-07-16 | Abbott Cardiovascular Systems Inc. | Implantable medical devices fabricated from branched polymers |
US20070282433A1 (en) * | 2006-06-01 | 2007-12-06 | Limon Timothy A | Stent with retention protrusions formed during crimping |
US8034287B2 (en) | 2006-06-01 | 2011-10-11 | Abbott Cardiovascular Systems Inc. | Radiation sterilization of medical devices |
US20070281073A1 (en) * | 2006-06-01 | 2007-12-06 | Gale David C | Enhanced adhesion of drug delivery coatings on stents |
CA2655158A1 (en) | 2006-06-05 | 2007-12-13 | C.R. Bard Inc. | Embolus blood clot filter utilizable with a single delivery system or a single retrieval system in one of a femoral or jugular access |
US20080124372A1 (en) * | 2006-06-06 | 2008-05-29 | Hossainy Syed F A | Morphology profiles for control of agent release rates from polymer matrices |
US20070286941A1 (en) * | 2006-06-13 | 2007-12-13 | Bin Huang | Surface treatment of a polymeric stent |
US8603530B2 (en) | 2006-06-14 | 2013-12-10 | Abbott Cardiovascular Systems Inc. | Nanoshell therapy |
US8048448B2 (en) | 2006-06-15 | 2011-11-01 | Abbott Cardiovascular Systems Inc. | Nanoshells for drug delivery |
US8535372B1 (en) | 2006-06-16 | 2013-09-17 | Abbott Cardiovascular Systems Inc. | Bioabsorbable stent with prohealing layer |
US8333000B2 (en) | 2006-06-19 | 2012-12-18 | Advanced Cardiovascular Systems, Inc. | Methods for improving stent retention on a balloon catheter |
US20070290412A1 (en) * | 2006-06-19 | 2007-12-20 | John Capek | Fabricating a stent with selected properties in the radial and axial directions |
US8017237B2 (en) | 2006-06-23 | 2011-09-13 | Abbott Cardiovascular Systems, Inc. | Nanoshells on polymers |
US9072820B2 (en) | 2006-06-26 | 2015-07-07 | Advanced Cardiovascular Systems, Inc. | Polymer composite stent with polymer particles |
US20070299511A1 (en) * | 2006-06-27 | 2007-12-27 | Gale David C | Thin stent coating |
US8128688B2 (en) | 2006-06-27 | 2012-03-06 | Abbott Cardiovascular Systems Inc. | Carbon coating on an implantable device |
US8815275B2 (en) | 2006-06-28 | 2014-08-26 | Boston Scientific Scimed, Inc. | Coatings for medical devices comprising a therapeutic agent and a metallic material |
US7794776B1 (en) | 2006-06-29 | 2010-09-14 | Abbott Cardiovascular Systems Inc. | Modification of polymer stents with radiation |
JP2009542359A (en) * | 2006-06-29 | 2009-12-03 | ボストン サイエンティフィック リミテッド | Medical device with selective covering |
US7740791B2 (en) | 2006-06-30 | 2010-06-22 | Advanced Cardiovascular Systems, Inc. | Method of fabricating a stent with features by blow molding |
US9265865B2 (en) * | 2006-06-30 | 2016-02-23 | Boston Scientific Scimed, Inc. | Stent having time-release indicator |
US20080009938A1 (en) * | 2006-07-07 | 2008-01-10 | Bin Huang | Stent with a radiopaque marker and method for making the same |
US7823263B2 (en) | 2006-07-11 | 2010-11-02 | Abbott Cardiovascular Systems Inc. | Method of removing stent islands from a stent |
US20080015578A1 (en) * | 2006-07-12 | 2008-01-17 | Dave Erickson | Orthopedic implants comprising bioabsorbable metal |
US7998404B2 (en) | 2006-07-13 | 2011-08-16 | Advanced Cardiovascular Systems, Inc. | Reduced temperature sterilization of stents |
US7757543B2 (en) | 2006-07-13 | 2010-07-20 | Advanced Cardiovascular Systems, Inc. | Radio frequency identification monitoring of stents |
US7794495B2 (en) | 2006-07-17 | 2010-09-14 | Advanced Cardiovascular Systems, Inc. | Controlled degradation of stents |
US7886419B2 (en) | 2006-07-18 | 2011-02-15 | Advanced Cardiovascular Systems, Inc. | Stent crimping apparatus and method |
US8016879B2 (en) | 2006-08-01 | 2011-09-13 | Abbott Cardiovascular Systems Inc. | Drug delivery after biodegradation of the stent scaffolding |
US9265866B2 (en) * | 2006-08-01 | 2016-02-23 | Abbott Cardiovascular Systems Inc. | Composite polymeric and metallic stent with radiopacity |
US20080091262A1 (en) * | 2006-10-17 | 2008-04-17 | Gale David C | Drug delivery after biodegradation of the stent scaffolding |
JP2009545407A (en) | 2006-08-02 | 2009-12-24 | ボストン サイエンティフィック サイムド,インコーポレイテッド | End prosthesis with 3D decomposition control |
DE102006038233A1 (en) | 2006-08-07 | 2008-02-14 | Biotronik Vi Patent Ag | Marker composite for medical implants |
DE102006038231A1 (en) | 2006-08-07 | 2008-02-14 | Biotronik Vi Patent Ag | Implant of a biocorrodible metallic material with a coating of an organosilicon compound |
DE102006038237A1 (en) | 2006-08-07 | 2008-02-14 | Biotronik Vi Patent Ag | marker alloy |
US9345819B2 (en) | 2006-08-07 | 2016-05-24 | Biotronik Vi Patent Ag | Marker alloy |
CN100409904C (en) * | 2006-08-14 | 2008-08-13 | 大连富精医疗器械有限公司 | Biodegradable magnesium alloy blood vessel rack |
US9173733B1 (en) | 2006-08-21 | 2015-11-03 | Abbott Cardiovascular Systems Inc. | Tracheobronchial implantable medical device and methods of use |
DE102006039346A1 (en) * | 2006-08-22 | 2008-03-13 | Biotronik Vi Patent Ag | Biocorrodible metallic implant with a coating or cavity filling of a PEG / PLGA copolymer |
DE102006042313A1 (en) * | 2006-09-06 | 2008-03-27 | Biotronik Vi Patent Ag | Biocorrodible metallic implant with a coating or cavity filling made of gelatin |
US7923022B2 (en) | 2006-09-13 | 2011-04-12 | Advanced Cardiovascular Systems, Inc. | Degradable polymeric implantable medical devices with continuous phase and discrete phase |
JP2010503469A (en) | 2006-09-14 | 2010-02-04 | ボストン サイエンティフィック リミテッド | Medical device having drug-eluting film |
US8052744B2 (en) | 2006-09-15 | 2011-11-08 | Boston Scientific Scimed, Inc. | Medical devices and methods of making the same |
EP2068782B1 (en) | 2006-09-15 | 2011-07-27 | Boston Scientific Limited | Bioerodible endoprostheses |
CA2663198A1 (en) * | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Medical devices |
WO2008034050A2 (en) * | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Endoprosthesis containing magnetic induction particles |
JP2010503490A (en) | 2006-09-15 | 2010-02-04 | ボストン サイエンティフィック リミテッド | Endoprosthesis with adjustable surface features |
DE602007011114D1 (en) * | 2006-09-15 | 2011-01-20 | Boston Scient Scimed Inc | BIODEGRADABLE ENDOPROTHESIS WITH BIOSTABILES INORGANIC LAYERS |
EP2081616B1 (en) * | 2006-09-15 | 2017-11-01 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
EP2068781A2 (en) * | 2006-09-18 | 2009-06-17 | Boston Scientific Limited | Medical devices |
US20080071358A1 (en) * | 2006-09-18 | 2008-03-20 | Boston Scientific Scimed, Inc. | Endoprostheses |
EP2073764A2 (en) * | 2006-09-18 | 2009-07-01 | Boston Scientific Limited | Controlling biodegradation of a medical instrument |
WO2008036543A2 (en) | 2006-09-18 | 2008-03-27 | C.R. Bard, Inc. | Single layer eptfe and discrete bio-resorbable rings |
US8002821B2 (en) * | 2006-09-18 | 2011-08-23 | Boston Scientific Scimed, Inc. | Bioerodible metallic ENDOPROSTHESES |
US7963942B2 (en) * | 2006-09-20 | 2011-06-21 | Boston Scientific Scimed, Inc. | Medical balloons with modified surfaces |
CN102512711A (en) * | 2006-09-22 | 2012-06-27 | 友和安股份公司 | Implants comprising biodegradable metals and method for manufacturing the same |
US10568652B2 (en) | 2006-09-29 | 2020-02-25 | Ethicon Llc | Surgical staples having attached drivers of different heights and stapling instruments for deploying the same |
WO2008045184A1 (en) * | 2006-10-05 | 2008-04-17 | Boston Scientific Limited | Polymer-free coatings for medical devices formed by plasma electrolytic deposition |
US20080090097A1 (en) * | 2006-10-11 | 2008-04-17 | The Penn State Research Foundation | Chemically and physically tailored structured thin film assemblies for corrosion prevention or promotion |
US20080097577A1 (en) * | 2006-10-20 | 2008-04-24 | Boston Scientific Scimed, Inc. | Medical device hydrogen surface treatment by electrochemical reduction |
WO2008051749A2 (en) | 2006-10-23 | 2008-05-02 | C. R. Bard, Inc. | Breast marker |
US7981150B2 (en) | 2006-11-09 | 2011-07-19 | Boston Scientific Scimed, Inc. | Endoprosthesis with coatings |
US9579077B2 (en) | 2006-12-12 | 2017-02-28 | C.R. Bard, Inc. | Multiple imaging mode tissue marker |
US8099849B2 (en) | 2006-12-13 | 2012-01-24 | Abbott Cardiovascular Systems Inc. | Optimizing fracture toughness of polymeric stent |
US7651527B2 (en) * | 2006-12-15 | 2010-01-26 | Medtronic Vascular, Inc. | Bioresorbable stent |
EP2101670B1 (en) | 2006-12-18 | 2013-07-31 | C.R.Bard, Inc. | Biopsy marker with in situ-generated imaging properties |
DE102006060501A1 (en) * | 2006-12-19 | 2008-06-26 | Biotronik Vi Patent Ag | Forming corrosion-inhibiting anodized coating on bio-corrodible magnesium alloy implant, treats implant in aqueous or alcoholic solution containing specified ion concentration |
US8728170B1 (en) | 2006-12-28 | 2014-05-20 | Boston Scientific Scimed, Inc. | Bioerodible nano-fibrous and nano-porous conductive composites |
JP5355418B2 (en) | 2006-12-28 | 2013-11-27 | ボストン サイエンティフィック リミテッド | Bioerodible endoprosthesis and method for manufacturing the bioerodible endoprosthesis |
US8684253B2 (en) | 2007-01-10 | 2014-04-01 | Ethicon Endo-Surgery, Inc. | Surgical instrument with wireless communication between a control unit of a robotic system and remote sensor |
US20080169332A1 (en) | 2007-01-11 | 2008-07-17 | Shelton Frederick E | Surgical stapling device with a curved cutting member |
WO2008087214A1 (en) * | 2007-01-19 | 2008-07-24 | Cinvention Ag | Porous, non-degradable implant made by powder molding |
US20080206441A1 (en) * | 2007-02-27 | 2008-08-28 | Medtronic Vascular, Inc. | Ion Beam Etching a Surface of an Implantable Medical Device |
US8070797B2 (en) | 2007-03-01 | 2011-12-06 | Boston Scientific Scimed, Inc. | Medical device with a porous surface for delivery of a therapeutic agent |
US8431149B2 (en) | 2007-03-01 | 2013-04-30 | Boston Scientific Scimed, Inc. | Coated medical devices for abluminal drug delivery |
DE102007015994A1 (en) | 2007-03-16 | 2008-09-18 | Biotronik Vi Patent Ag | Stent, has segments formed by meander-shaped rod with opposite meander sheets from flexible material in contracted starting position, where fine structure of rods overlaid basic structure in form of compensation loop formed into sheets |
DE102007016415A1 (en) | 2007-04-05 | 2008-10-09 | Biotronik Vi Patent Ag | Medical vessel-supporting implant i.e. stent, for use in stenosis therapy of coronary vessel, has props shaped in joint such that bending load occurred during dilating arrives from outer side of angle into props |
US8067054B2 (en) | 2007-04-05 | 2011-11-29 | Boston Scientific Scimed, Inc. | Stents with ceramic drug reservoir layer and methods of making and using the same |
US8262723B2 (en) | 2007-04-09 | 2012-09-11 | Abbott Cardiovascular Systems Inc. | Implantable medical devices fabricated from polymer blends with star-block copolymers |
US7976915B2 (en) * | 2007-05-23 | 2011-07-12 | Boston Scientific Scimed, Inc. | Endoprosthesis with select ceramic morphology |
US7829008B2 (en) | 2007-05-30 | 2010-11-09 | Abbott Cardiovascular Systems Inc. | Fabricating a stent from a blow molded tube |
US7959857B2 (en) | 2007-06-01 | 2011-06-14 | Abbott Cardiovascular Systems Inc. | Radiation sterilization of medical devices |
US8931682B2 (en) | 2007-06-04 | 2015-01-13 | Ethicon Endo-Surgery, Inc. | Robotically-controlled shaft based rotary drive systems for surgical instruments |
US11672531B2 (en) | 2007-06-04 | 2023-06-13 | Cilag Gmbh International | Rotary drive systems for surgical instruments |
US8202528B2 (en) | 2007-06-05 | 2012-06-19 | Abbott Cardiovascular Systems Inc. | Implantable medical devices with elastomeric block copolymer coatings |
US8293260B2 (en) | 2007-06-05 | 2012-10-23 | Abbott Cardiovascular Systems Inc. | Elastomeric copolymer coatings containing poly (tetramethyl carbonate) for implantable medical devices |
US20080306582A1 (en) * | 2007-06-05 | 2008-12-11 | Yunbing Wang | Implantable medical devices with elastomeric copolymer coatings |
US8425591B1 (en) | 2007-06-11 | 2013-04-23 | Abbott Cardiovascular Systems Inc. | Methods of forming polymer-bioceramic composite medical devices with bioceramic particles |
US8048441B2 (en) | 2007-06-25 | 2011-11-01 | Abbott Cardiovascular Systems, Inc. | Nanobead releasing medical devices |
US7901452B2 (en) | 2007-06-27 | 2011-03-08 | Abbott Cardiovascular Systems Inc. | Method to fabricate a stent having selected morphology to reduce restenosis |
DE102007030438A1 (en) | 2007-06-29 | 2009-01-08 | Biotronik Vi Patent Ag | Implant for use in modern medical technology, is made of bio-corrosive magnesium alloy and having coating of polyorthoester that is hydrophob and is wet by water such that hydrolytic dismantling of polymer in aqueous media is retarded |
US11849941B2 (en) | 2007-06-29 | 2023-12-26 | Cilag Gmbh International | Staple cartridge having staple cavities extending at a transverse angle relative to a longitudinal cartridge axis |
US7955381B1 (en) | 2007-06-29 | 2011-06-07 | Advanced Cardiovascular Systems, Inc. | Polymer-bioceramic composite implantable medical device with different types of bioceramic particles |
US7942926B2 (en) * | 2007-07-11 | 2011-05-17 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8002823B2 (en) * | 2007-07-11 | 2011-08-23 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US9284409B2 (en) | 2007-07-19 | 2016-03-15 | Boston Scientific Scimed, Inc. | Endoprosthesis having a non-fouling surface |
US20090030500A1 (en) * | 2007-07-27 | 2009-01-29 | Jan Weber | Iron Ion Releasing Endoprostheses |
US8815273B2 (en) * | 2007-07-27 | 2014-08-26 | Boston Scientific Scimed, Inc. | Drug eluting medical devices having porous layers |
US7931683B2 (en) * | 2007-07-27 | 2011-04-26 | Boston Scientific Scimed, Inc. | Articles having ceramic coated surfaces |
WO2009018340A2 (en) * | 2007-07-31 | 2009-02-05 | Boston Scientific Scimed, Inc. | Medical device coating by laser cladding |
JP2010535541A (en) * | 2007-08-03 | 2010-11-25 | ボストン サイエンティフィック リミテッド | Coating for medical devices with large surface area |
DE102007038799A1 (en) | 2007-08-17 | 2009-02-19 | Biotronik Vi Patent Ag | Implant made of a biocorrodible magnesium alloy and coated with a biocorrodible polyphosphazene |
US20090048659A1 (en) * | 2007-08-17 | 2009-02-19 | Boston Scientific Scimed, Inc. | Medical devices having sol-gel derived ceramic regions with molded submicron surface features |
JP5426553B2 (en) | 2007-09-12 | 2014-02-26 | トランスルミナル テクノロジーズ リミテッド ライアビリティー カンパニー | Closure device, placement device, and method of placing a closure device |
US9456816B2 (en) | 2007-09-12 | 2016-10-04 | Transluminal Technologies, Llc | Closure device, deployment apparatus, and method of deploying a closure device |
US8876861B2 (en) * | 2007-09-12 | 2014-11-04 | Transluminal Technologies, Inc. | Closure device, deployment apparatus, and method of deploying a closure device |
US8052745B2 (en) | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US8029554B2 (en) * | 2007-11-02 | 2011-10-04 | Boston Scientific Scimed, Inc. | Stent with embedded material |
US20090118809A1 (en) * | 2007-11-02 | 2009-05-07 | Torsten Scheuermann | Endoprosthesis with porous reservoir and non-polymer diffusion layer |
US7938855B2 (en) | 2007-11-02 | 2011-05-10 | Boston Scientific Scimed, Inc. | Deformable underlayer for stent |
US20090118813A1 (en) * | 2007-11-02 | 2009-05-07 | Torsten Scheuermann | Nano-patterned implant surfaces |
US8216632B2 (en) | 2007-11-02 | 2012-07-10 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US20090143855A1 (en) * | 2007-11-29 | 2009-06-04 | Boston Scientific Scimed, Inc. | Medical Device Including Drug-Loaded Fibers |
US8118857B2 (en) | 2007-11-29 | 2012-02-21 | Boston Scientific Corporation | Medical articles that stimulate endothelial cell migration |
EP2231216B1 (en) * | 2007-12-14 | 2012-08-08 | Boston Scientific Scimed, Inc. | Drug-eluting endoprosthesis |
DE102007061647A1 (en) | 2007-12-20 | 2009-07-02 | Biotronik Vi Patent Ag | Implant with a body made of a biocorrodible alloy |
US8801778B2 (en) | 2007-12-20 | 2014-08-12 | Biotronik Vi Patent Ag | Implant with a base body of a biocorrodible alloy |
US9072810B2 (en) | 2008-01-17 | 2015-07-07 | The University Of Hong Kong | Implant for tissue engineering |
US8172908B2 (en) * | 2008-01-17 | 2012-05-08 | The University Of Hong Kong | Implant for tissue engineering |
DE102008006455A1 (en) | 2008-01-29 | 2009-07-30 | Biotronik Vi Patent Ag | Implant comprising a body made of a biocorrodible alloy and a corrosion-inhibiting coating |
DE102008006654A1 (en) | 2008-01-30 | 2009-08-06 | Biotronik Vi Patent Ag | Implant with a body made of a biocorrodible alloy |
WO2009099767A2 (en) | 2008-01-31 | 2009-08-13 | C.R. Bard, Inc. | Biopsy tissue marker |
DE102008002601A1 (en) | 2008-02-05 | 2009-08-06 | Biotronik Vi Patent Ag | Implant with a body made of a biocorrodible iron alloy |
US8636736B2 (en) | 2008-02-14 | 2014-01-28 | Ethicon Endo-Surgery, Inc. | Motorized surgical cutting and fastening instrument |
BRPI0901282A2 (en) | 2008-02-14 | 2009-11-17 | Ethicon Endo Surgery Inc | surgical cutting and fixation instrument with rf electrodes |
US7866527B2 (en) | 2008-02-14 | 2011-01-11 | Ethicon Endo-Surgery, Inc. | Surgical stapling apparatus with interlockable firing system |
KR101289122B1 (en) | 2008-03-18 | 2013-07-23 | 한국보건산업진흥원 | COMPLEX IMPLANTS INFILTERATED WITH BIODEGRADABLE Mg(ALLOYS) INSIDE POROUS STRUCTURAL MATERIALS AND METHOD FOR MANUFACTURING THE SAME |
KR101398212B1 (en) * | 2008-03-18 | 2014-05-26 | 삼성전자주식회사 | Memory device and encoding and/or decoding method |
CN101297777B (en) * | 2008-03-26 | 2010-06-09 | 江阴法尔胜佩尔新材料科技有限公司 | Preparation for processing biodegradable magnesium alloy intravascular stent |
EP2271380B1 (en) | 2008-04-22 | 2013-03-20 | Boston Scientific Scimed, Inc. | Medical devices having a coating of inorganic material |
US8932346B2 (en) | 2008-04-24 | 2015-01-13 | Boston Scientific Scimed, Inc. | Medical devices having inorganic particle layers |
US7998192B2 (en) | 2008-05-09 | 2011-08-16 | Boston Scientific Scimed, Inc. | Endoprostheses |
US20090297581A1 (en) * | 2008-05-28 | 2009-12-03 | Boston Scientific Scimed, Inc. | Medical devices having electrodeposited coatings |
US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
DE102008002471A1 (en) | 2008-06-17 | 2009-12-24 | Biotronik Vi Patent Ag | Stent with a coating or a base body containing a lithium salt, and use of lithium salts for restenosis prophylaxis |
US8449603B2 (en) | 2008-06-18 | 2013-05-28 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
WO2009158333A2 (en) * | 2008-06-25 | 2009-12-30 | Boston Scientific Scimed, Inc. | Medical devices for delivery of therapeutic agent in conjunction with galvanic corrosion |
US8298466B1 (en) | 2008-06-27 | 2012-10-30 | Abbott Cardiovascular Systems Inc. | Method for fabricating medical devices with porous polymeric structures |
US20100004733A1 (en) * | 2008-07-02 | 2010-01-07 | Boston Scientific Scimed, Inc. | Implants Including Fractal Structures |
DE202008018000U1 (en) | 2008-07-07 | 2011-04-21 | Syntellix Ag | Osterosynthetic implant for implantation in the human or animal body |
DE102008040253A1 (en) * | 2008-07-08 | 2010-01-14 | Biotronik Vi Patent Ag | Implant system with a functional implant made of degradable metal material |
DE102008040791A1 (en) | 2008-07-28 | 2010-02-04 | Biotronik Vi Patent Ag | Endoprosthesis and method of making the same |
DE102008040787A1 (en) | 2008-07-28 | 2010-02-04 | Biotronik Vi Patent Ag | Biocorrodible implant with a coating containing a hydrogel |
DE102008040786A1 (en) | 2008-07-28 | 2010-02-04 | Biotronik Vi Patent Ag | Biocorrodible implant with a coating containing a drug-carrying polymer matrix |
US7985252B2 (en) | 2008-07-30 | 2011-07-26 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
EP2323709A2 (en) | 2008-08-14 | 2011-05-25 | Boston Scientific Scimed, Inc. | Medical devices having electrodeposited conductive polymer coatings |
US9005230B2 (en) | 2008-09-23 | 2015-04-14 | Ethicon Endo-Surgery, Inc. | Motorized surgical instrument |
US9386983B2 (en) | 2008-09-23 | 2016-07-12 | Ethicon Endo-Surgery, Llc | Robotically-controlled motorized surgical instrument |
US11648005B2 (en) | 2008-09-23 | 2023-05-16 | Cilag Gmbh International | Robotically-controlled motorized surgical instrument with an end effector |
US9327061B2 (en) | 2008-09-23 | 2016-05-03 | Senorx, Inc. | Porous bioabsorbable implant |
US8210411B2 (en) | 2008-09-23 | 2012-07-03 | Ethicon Endo-Surgery, Inc. | Motor-driven surgical cutting instrument |
US9119906B2 (en) | 2008-09-24 | 2015-09-01 | Integran Technologies, Inc. | In-vivo biodegradable medical implant |
DE102008042578A1 (en) | 2008-10-02 | 2010-04-08 | Biotronik Vi Patent Ag | Implant with a body made of a biocorrodible manganese alloy |
DE102008042576A1 (en) | 2008-10-02 | 2010-04-08 | Biotronik Vi Patent Ag | Medical implant for use as vascular implant, preferably cardiovascular implant or orthopedic implants for fixing human or animal tissue, vessels, bones or bone fragments, comprises bio-corrosive alloy composition |
US8382824B2 (en) | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
US8608045B2 (en) | 2008-10-10 | 2013-12-17 | Ethicon Endo-Sugery, Inc. | Powered surgical cutting and stapling apparatus with manually retractable firing system |
DE102008043277A1 (en) | 2008-10-29 | 2010-05-06 | Biotronik Vi Patent Ag | Implant made of a biocorrodible iron or magnesium alloy |
DE102008043736A1 (en) | 2008-11-14 | 2010-05-20 | Biotronik Vi Patent Ag | Implant, preferably stent, comprises completely or partially biocorrodible metallic material, where metallic material has properties to form alkaline product on decomposition in aqueous environment |
DE102008043970A1 (en) * | 2008-11-21 | 2010-05-27 | Biotronik Vi Patent Ag | A method for producing a corrosion-inhibiting coating on an implant of a biocorrodible magnesium alloy and implant produced by the method |
DE102008044221A1 (en) | 2008-12-01 | 2010-06-02 | Biotronik Vi Patent Ag | Stent with a structure of a biocorrodible material and a controlled corrosion behavior |
US8231980B2 (en) * | 2008-12-03 | 2012-07-31 | Boston Scientific Scimed, Inc. | Medical implants including iridium oxide |
EP3005971B1 (en) | 2008-12-30 | 2023-04-26 | C. R. Bard, Inc. | Marker delivery device for tissue marker placement |
EP2213314B1 (en) | 2009-01-30 | 2016-03-23 | Biotronik VI Patent AG | Implant with a base body of a biocorrodible magnesium alloy |
US20100217370A1 (en) * | 2009-02-20 | 2010-08-26 | Boston Scientific Scimed, Inc. | Bioerodible Endoprosthesis |
US8267992B2 (en) * | 2009-03-02 | 2012-09-18 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
US8071156B2 (en) * | 2009-03-04 | 2011-12-06 | Boston Scientific Scimed, Inc. | Endoprostheses |
DE102009002153A1 (en) | 2009-04-02 | 2010-10-21 | Biotronik Vi Patent Ag | Implant of a biocorrodible metallic material with a nanoparticle-containing silane coating and associated manufacturing method |
US8435281B2 (en) | 2009-04-10 | 2013-05-07 | Boston Scientific Scimed, Inc. | Bioerodible, implantable medical devices incorporating supersaturated magnesium alloys |
EP2421468B1 (en) * | 2009-04-20 | 2016-12-07 | Rox Medical, Inc. | Device for establishing an artificial arterio-venous fistula |
JP5784005B2 (en) * | 2009-04-22 | 2015-09-24 | ユー アンド アイ コーポレーション | Biodegradable implant and method for producing the same |
US20100274352A1 (en) * | 2009-04-24 | 2010-10-28 | Boston Scientific Scrimed, Inc. | Endoprosthesis with Selective Drug Coatings |
US8287937B2 (en) * | 2009-04-24 | 2012-10-16 | Boston Scientific Scimed, Inc. | Endoprosthese |
EP2260884A1 (en) | 2009-06-09 | 2010-12-15 | Heller, Jorg | Implant system with a temporary implant and method for influencing the corrosion rate of an implant |
DE102009025511A1 (en) * | 2009-06-19 | 2010-12-23 | Qualimed Innovative Medizin-Produkte Gmbh | Implant with a resorbable metallic material |
EP2266507B1 (en) | 2009-06-22 | 2015-07-29 | Biotronik VI Patent AG | Stent having improved stent design |
EP2266638A3 (en) * | 2009-06-25 | 2014-08-13 | Biotronik VI Patent AG | Biocorrodible implant having an active coating |
EP2266508A1 (en) * | 2009-06-25 | 2010-12-29 | Biotronik VI Patent AG | Stent with improved stent design |
US20110022158A1 (en) * | 2009-07-22 | 2011-01-27 | Boston Scientific Scimed, Inc. | Bioerodible Medical Implants |
AU2010278893B2 (en) | 2009-07-29 | 2014-02-27 | C.R. Bard, Inc. | Tubular filter |
US20110034990A1 (en) * | 2009-08-06 | 2011-02-10 | Alexander Borck | Biocorrodible implant with active coating |
US8512483B2 (en) | 2009-09-28 | 2013-08-20 | Biotronik Vi Patent Ag | Implant and method for manufacturing same |
ES2487631T3 (en) | 2009-10-30 | 2014-08-22 | Acrostak Corp Bvi, Tortola | Biodegradable implantable medical device formed from a material based on superpure magnesium |
US10240419B2 (en) | 2009-12-08 | 2019-03-26 | Baker Hughes, A Ge Company, Llc | Downhole flow inhibition tool and method of unplugging a seat |
US8808353B2 (en) | 2010-01-30 | 2014-08-19 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds having a low crossing profile |
US8568471B2 (en) | 2010-01-30 | 2013-10-29 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds |
US8668732B2 (en) | 2010-03-23 | 2014-03-11 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
SG183382A1 (en) | 2010-03-25 | 2012-09-27 | Biotronik Ag | Implant made of a biodegradable magnesium alloy |
EP2371404A3 (en) | 2010-03-30 | 2014-08-20 | Biotronik AG | Medical implant having a coating composed of or containing at least one nitrostatin active substance |
EP2384725B1 (en) | 2010-05-06 | 2018-07-04 | Biotronik AG | Biocorrodable implant in which corrosion may be triggered or accelerated after implantation by means of an external stimulus |
US8709072B2 (en) | 2010-05-13 | 2014-04-29 | Boston Scientific Scimed, Inc. | Endoprosthesis |
WO2011143284A1 (en) | 2010-05-14 | 2011-11-17 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US8389041B2 (en) | 2010-06-17 | 2013-03-05 | Abbott Cardiovascular Systems, Inc. | Systems and methods for rotating and coating an implantable device |
WO2011163236A2 (en) | 2010-06-21 | 2011-12-29 | Zorion Medical, Inc. | Bioabsorbable implants |
EP2585125B1 (en) | 2010-06-25 | 2014-11-19 | Fort Wayne Metals Research Products Corporation | Biodegradable composite wire for medical devices |
EP2399620B1 (en) | 2010-06-28 | 2016-08-10 | Biotronik AG | Implant and method for producing the same |
EP2433659A3 (en) | 2010-08-13 | 2014-09-03 | Biotronik AG | Implant and method for the production thereof |
BR112013004768A2 (en) | 2010-08-30 | 2017-11-21 | Sinusys Coporation | devices and methods for dilating a parasanal sinus opening and for treating sinusitis |
US8657176B2 (en) | 2010-09-30 | 2014-02-25 | Ethicon Endo-Surgery, Inc. | Tissue thickness compensator for a surgical stapler |
US11849952B2 (en) | 2010-09-30 | 2023-12-26 | Cilag Gmbh International | Staple cartridge comprising staples positioned within a compressible portion thereof |
US9320523B2 (en) | 2012-03-28 | 2016-04-26 | Ethicon Endo-Surgery, Llc | Tissue thickness compensator comprising tissue ingrowth features |
US11812965B2 (en) | 2010-09-30 | 2023-11-14 | Cilag Gmbh International | Layer of material for a surgical end effector |
US9629814B2 (en) | 2010-09-30 | 2017-04-25 | Ethicon Endo-Surgery, Llc | Tissue thickness compensator configured to redistribute compressive forces |
US9272406B2 (en) | 2010-09-30 | 2016-03-01 | Ethicon Endo-Surgery, Llc | Fastener cartridge comprising a cutting member for releasing a tissue thickness compensator |
US10945731B2 (en) | 2010-09-30 | 2021-03-16 | Ethicon Llc | Tissue thickness compensator comprising controlled release and expansion |
US8695866B2 (en) | 2010-10-01 | 2014-04-15 | Ethicon Endo-Surgery, Inc. | Surgical instrument having a power control circuit |
EP2438891A1 (en) | 2010-10-08 | 2012-04-11 | Biotronik AG | Stent having increased visibility in the X-ray image |
EP2446863A1 (en) | 2010-10-29 | 2012-05-02 | Biotronik AG | Stent with radially asymmetric force distribution |
MX356254B (en) | 2010-11-09 | 2018-05-21 | Transluminal Tech Llc | Specially designed magnesium-aluminum alloys and medical uses thereof in a hemodynamic environment. |
US8961592B2 (en) | 2010-11-12 | 2015-02-24 | Biotronik Ag | Functionalized RGD peptidomimetics and their manufacture, and implant having a coating containing such functional-ized RGD peptidomimetics |
DE102010043814A1 (en) | 2010-11-12 | 2012-05-16 | Biotronik Ag | Implant, useful as a stent, a sensor or an electrode, comprises a coating comprising functionalized arginine-glycine-aspartic acid peptidomimetic compounds |
EP2452702B1 (en) | 2010-11-12 | 2015-03-04 | Biotronik AG | Functionalized RGD peptidomimetics and their manufacture, and implant having a coating containing such functionalized RGD peptidomimetics |
US8986369B2 (en) | 2010-12-01 | 2015-03-24 | Zorion Medical, Inc. | Magnesium-based absorbable implants |
US20120158123A1 (en) | 2010-12-15 | 2012-06-21 | Biotronik Ag | Polymer stent |
CA2834649C (en) | 2011-04-29 | 2021-02-16 | Ethicon Endo-Surgery, Inc. | Staple cartridge comprising staples positioned within a compressible portion thereof |
US9072535B2 (en) | 2011-05-27 | 2015-07-07 | Ethicon Endo-Surgery, Inc. | Surgical stapling instruments with rotatable staple deployment arrangements |
WO2012173555A1 (en) | 2011-06-13 | 2012-12-20 | Dentsply Ih Ab | Collagen coated article |
US9707739B2 (en) | 2011-07-22 | 2017-07-18 | Baker Hughes Incorporated | Intermetallic metallic composite, method of manufacture thereof and articles comprising the same |
US8726483B2 (en) | 2011-07-29 | 2014-05-20 | Abbott Cardiovascular Systems Inc. | Methods for uniform crimping and deployment of a polymer scaffold |
US9033055B2 (en) | 2011-08-17 | 2015-05-19 | Baker Hughes Incorporated | Selectively degradable passage restriction and method |
US9090956B2 (en) | 2011-08-30 | 2015-07-28 | Baker Hughes Incorporated | Aluminum alloy powder metal compact |
DE102011115884A1 (en) * | 2011-10-14 | 2013-04-18 | Geb-Vet Ug | Milk gland insert for the treatment of mastitis |
WO2013059715A2 (en) * | 2011-10-20 | 2013-04-25 | Medtronic Vascular Inc. | Iron based alloys for bioabsorbable stent |
US9010416B2 (en) | 2012-01-25 | 2015-04-21 | Baker Hughes Incorporated | Tubular anchoring system and a seat for use in the same |
GB2499211B (en) | 2012-02-08 | 2016-03-02 | Cook Medical Technologies Llc | Bioabsorbable stent and implantable medical device |
US9138569B2 (en) | 2012-02-29 | 2015-09-22 | SinuSys Corporation | Devices and methods for dilating a paranasal sinus opening and for treating sinusitis |
MX350846B (en) | 2012-03-28 | 2017-09-22 | Ethicon Endo Surgery Inc | Tissue thickness compensator comprising capsules defining a low pressure environment. |
BR112014024102B1 (en) | 2012-03-28 | 2022-03-03 | Ethicon Endo-Surgery, Inc | CLAMP CARTRIDGE ASSEMBLY FOR A SURGICAL INSTRUMENT AND END ACTUATOR ASSEMBLY FOR A SURGICAL INSTRUMENT |
US9101358B2 (en) | 2012-06-15 | 2015-08-11 | Ethicon Endo-Surgery, Inc. | Articulatable surgical instrument comprising a firing drive |
US9289256B2 (en) | 2012-06-28 | 2016-03-22 | Ethicon Endo-Surgery, Llc | Surgical end effectors having angled tissue-contacting surfaces |
US9649111B2 (en) | 2012-06-28 | 2017-05-16 | Ethicon Endo-Surgery, Llc | Replaceable clip cartridge for a clip applier |
US9226751B2 (en) | 2012-06-28 | 2016-01-05 | Ethicon Endo-Surgery, Inc. | Surgical instrument system including replaceable end effectors |
US20140001231A1 (en) | 2012-06-28 | 2014-01-02 | Ethicon Endo-Surgery, Inc. | Firing system lockout arrangements for surgical instruments |
WO2014028599A1 (en) | 2012-08-14 | 2014-02-20 | Guo Yuebin | A biodegradable medical device having an adjustable degradation rate and methods of making the same |
DE102012021187A1 (en) * | 2012-10-30 | 2014-04-30 | Qualimed Innovative Medizinprodukte Gmbh | Bioresorbable stent made of a composite material |
US9504554B2 (en) | 2013-01-16 | 2016-11-29 | Biotronik Ag | Microstructured absorbable implant |
CN105142687B (en) | 2013-02-15 | 2017-12-08 | 波士顿科学国际有限公司 | Bioerodible magnesium alloy micro-structural for interior prosthese |
US10849667B2 (en) * | 2013-02-22 | 2020-12-01 | University of Pittsburgh—of the Commonwealth System of Higher Education | Biodegradable, magnesium-containing bone screws, methods for their preparation and medical applications therefor |
BR112015021098B1 (en) | 2013-03-01 | 2022-02-15 | Ethicon Endo-Surgery, Inc | COVERAGE FOR A JOINT JOINT AND SURGICAL INSTRUMENT |
CA2906945A1 (en) * | 2013-03-15 | 2014-09-18 | Incube Labs, Llc | Multi-stage biodegradable drug delivery platform |
BR112015026109B1 (en) | 2013-04-16 | 2022-02-22 | Ethicon Endo-Surgery, Inc | surgical instrument |
US9687263B2 (en) | 2013-05-30 | 2017-06-27 | SinuSys Corporation | Devices and methods for inserting a sinus dilator |
US9510828B2 (en) | 2013-08-23 | 2016-12-06 | Ethicon Endo-Surgery, Llc | Conductor arrangements for electrically powered surgical instruments with rotatable end effectors |
US9816339B2 (en) | 2013-09-03 | 2017-11-14 | Baker Hughes, A Ge Company, Llc | Plug reception assembly and method of reducing restriction in a borehole |
USD716451S1 (en) | 2013-09-24 | 2014-10-28 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
USD715442S1 (en) | 2013-09-24 | 2014-10-14 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
USD715942S1 (en) | 2013-09-24 | 2014-10-21 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
USD716450S1 (en) | 2013-09-24 | 2014-10-28 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
CN105848690A (en) | 2013-10-29 | 2016-08-10 | 波士顿科学国际有限公司 | Bioerodible magnesium alloy microstructures for endoprostheses |
US11167343B2 (en) | 2014-02-21 | 2021-11-09 | Terves, Llc | Galvanically-active in situ formed particles for controlled rate dissolving tools |
US10865465B2 (en) | 2017-07-27 | 2020-12-15 | Terves, Llc | Degradable metal matrix composite |
US10150713B2 (en) | 2014-02-21 | 2018-12-11 | Terves, Inc. | Fluid activated disintegrating metal system |
US10013049B2 (en) | 2014-03-26 | 2018-07-03 | Ethicon Llc | Power management through sleep options of segmented circuit and wake up control |
US9863020B2 (en) * | 2014-04-03 | 2018-01-09 | University of Pittsburgh—of the Commonwealth System of Higher Education | Biodegradable metal alloys |
JP6532889B2 (en) | 2014-04-16 | 2019-06-19 | エシコン エルエルシーEthicon LLC | Fastener cartridge assembly and staple holder cover arrangement |
US20150297223A1 (en) | 2014-04-16 | 2015-10-22 | Ethicon Endo-Surgery, Inc. | Fastener cartridges including extensions having different configurations |
BR112016023698B1 (en) | 2014-04-16 | 2022-07-26 | Ethicon Endo-Surgery, Llc | FASTENER CARTRIDGE FOR USE WITH A SURGICAL INSTRUMENT |
WO2015171585A1 (en) | 2014-05-05 | 2015-11-12 | The University Of Toledo | Biodegradable magnesium alloys and composites |
JP2017524459A (en) | 2014-07-22 | 2017-08-31 | バイオトロニック アクチェンゲゼルシャフト | Biodegradable metal stent and method |
US9737301B2 (en) | 2014-09-05 | 2017-08-22 | Ethicon Llc | Monitoring device degradation based on component evaluation |
BR112017004361B1 (en) | 2014-09-05 | 2023-04-11 | Ethicon Llc | ELECTRONIC SYSTEM FOR A SURGICAL INSTRUMENT |
US10238397B2 (en) * | 2014-09-08 | 2019-03-26 | Stryker Corporation | Vaso-occlusive devices with in-situ stiffening |
US9924944B2 (en) | 2014-10-16 | 2018-03-27 | Ethicon Llc | Staple cartridge comprising an adjunct material |
US11141153B2 (en) | 2014-10-29 | 2021-10-12 | Cilag Gmbh International | Staple cartridges comprising driver arrangements |
US10517594B2 (en) | 2014-10-29 | 2019-12-31 | Ethicon Llc | Cartridge assemblies for surgical staplers |
EP3229852B1 (en) * | 2014-12-12 | 2022-09-28 | University of Pittsburgh - Of the Commonwealth System of Higher Education | ULTRAHIGH DUCTILITY, NOVEL Mg-Li BASED ALLOYS FOR BIOMEDICAL APPLICATIONS |
US9987000B2 (en) | 2014-12-18 | 2018-06-05 | Ethicon Llc | Surgical instrument assembly comprising a flexible articulation system |
US9943309B2 (en) | 2014-12-18 | 2018-04-17 | Ethicon Llc | Surgical instruments with articulatable end effectors and movable firing beam support arrangements |
MX2017008108A (en) | 2014-12-18 | 2018-03-06 | Ethicon Llc | Surgical instrument with an anvil that is selectively movable about a discrete non-movable axis relative to a staple cartridge. |
US10085748B2 (en) | 2014-12-18 | 2018-10-02 | Ethicon Llc | Locking arrangements for detachable shaft assemblies with articulatable surgical end effectors |
US9999527B2 (en) | 2015-02-11 | 2018-06-19 | Abbott Cardiovascular Systems Inc. | Scaffolds having radiopaque markers |
DE102015102181A1 (en) | 2015-02-16 | 2016-08-18 | Biotronik Ag | Vascular support and method for producing a vascular support |
US11154301B2 (en) | 2015-02-27 | 2021-10-26 | Cilag Gmbh International | Modular stapling assembly |
US10378303B2 (en) | 2015-03-05 | 2019-08-13 | Baker Hughes, A Ge Company, Llc | Downhole tool and method of forming the same |
US10441279B2 (en) | 2015-03-06 | 2019-10-15 | Ethicon Llc | Multiple level thresholds to modify operation of powered surgical instruments |
JP2020121162A (en) | 2015-03-06 | 2020-08-13 | エシコン エルエルシーEthicon LLC | Time dependent evaluation of sensor data to determine stability element, creep element and viscoelastic element of measurement |
JP2018515156A (en) | 2015-03-11 | 2018-06-14 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Microstructure of biodegradable magnesium alloys for endoprostheses |
JP6089053B2 (en) * | 2015-03-16 | 2017-03-01 | 有限会社エスク | Biodegradable metal surface modified stent with anticorrosive ability |
JP2016187501A (en) * | 2015-03-30 | 2016-11-04 | テルモ株式会社 | Medical implant |
US10390825B2 (en) | 2015-03-31 | 2019-08-27 | Ethicon Llc | Surgical instrument with progressive rotary drive systems |
US9700443B2 (en) | 2015-06-12 | 2017-07-11 | Abbott Cardiovascular Systems Inc. | Methods for attaching a radiopaque marker to a scaffold |
CN107847231B (en) * | 2015-07-14 | 2021-07-20 | 摩尔研究应用有限公司 | Devices, systems, and methods for monitoring a surgical site |
US10221637B2 (en) | 2015-08-11 | 2019-03-05 | Baker Hughes, A Ge Company, Llc | Methods of manufacturing dissolvable tools via liquid-solid state molding |
US10105139B2 (en) | 2015-09-23 | 2018-10-23 | Ethicon Llc | Surgical stapler having downstream current-based motor control |
US10271849B2 (en) | 2015-09-30 | 2019-04-30 | Ethicon Llc | Woven constructs with interlocked standing fibers |
US11890015B2 (en) | 2015-09-30 | 2024-02-06 | Cilag Gmbh International | Compressible adjunct with crossing spacer fibers |
US10016810B2 (en) | 2015-12-14 | 2018-07-10 | Baker Hughes, A Ge Company, Llc | Methods of manufacturing degradable tools using a galvanic carrier and tools manufactured thereof |
US10292704B2 (en) | 2015-12-30 | 2019-05-21 | Ethicon Llc | Mechanisms for compensating for battery pack failure in powered surgical instruments |
CN105671391B (en) * | 2016-01-19 | 2020-08-04 | 周倩 | Fully-degradable magnesium alloy and preparation method thereof |
US11213293B2 (en) | 2016-02-09 | 2022-01-04 | Cilag Gmbh International | Articulatable surgical instruments with single articulation link arrangements |
JP6911054B2 (en) | 2016-02-09 | 2021-07-28 | エシコン エルエルシーEthicon LLC | Surgical instruments with asymmetric joint composition |
US10448948B2 (en) | 2016-02-12 | 2019-10-22 | Ethicon Llc | Mechanisms for compensating for drivetrain failure in powered surgical instruments |
JP2017153857A (en) * | 2016-03-04 | 2017-09-07 | 学校法人東海大学 | Biodegradable embolic coil |
EP3435929B1 (en) | 2016-03-29 | 2020-05-20 | Cardinal Health Switzerland 515 GmbH | Contracting stent with bioresorbable struts |
US11607239B2 (en) | 2016-04-15 | 2023-03-21 | Cilag Gmbh International | Systems and methods for controlling a surgical stapling and cutting instrument |
US10357247B2 (en) | 2016-04-15 | 2019-07-23 | Ethicon Llc | Surgical instrument with multiple program responses during a firing motion |
US10828028B2 (en) | 2016-04-15 | 2020-11-10 | Ethicon Llc | Surgical instrument with multiple program responses during a firing motion |
US10426467B2 (en) | 2016-04-15 | 2019-10-01 | Ethicon Llc | Surgical instrument with detection sensors |
US10433840B2 (en) | 2016-04-18 | 2019-10-08 | Ethicon Llc | Surgical instrument comprising a replaceable cartridge jaw |
US20170296173A1 (en) | 2016-04-18 | 2017-10-19 | Ethicon Endo-Surgery, Llc | Method for operating a surgical instrument |
US10492785B2 (en) | 2016-12-21 | 2019-12-03 | Ethicon Llc | Shaft assembly comprising a lockout |
US20180168615A1 (en) | 2016-12-21 | 2018-06-21 | Ethicon Endo-Surgery, Llc | Method of deforming staples from two different types of staple cartridges with the same surgical stapling instrument |
JP7010956B2 (en) | 2016-12-21 | 2022-01-26 | エシコン エルエルシー | How to staple tissue |
US10537325B2 (en) | 2016-12-21 | 2020-01-21 | Ethicon Llc | Staple forming pocket arrangement to accommodate different types of staples |
US10758230B2 (en) | 2016-12-21 | 2020-09-01 | Ethicon Llc | Surgical instrument with primary and safety processors |
US11571210B2 (en) | 2016-12-21 | 2023-02-07 | Cilag Gmbh International | Firing assembly comprising a multiple failed-state fuse |
WO2018131476A1 (en) | 2017-01-10 | 2018-07-19 | 不二ライトメタル株式会社 | Magnesium alloy |
AU2018211835B2 (en) * | 2017-01-30 | 2022-10-27 | Fuji Light Metal Co., Ltd. | High performance bioabsorbable stent |
CN107198796B (en) * | 2017-05-22 | 2020-08-25 | 北京科技大学 | Biomedical Zn-Mn-Cu zinc alloy and preparation method thereof |
US10307170B2 (en) | 2017-06-20 | 2019-06-04 | Ethicon Llc | Method for closed loop control of motor velocity of a surgical stapling and cutting instrument |
US10881399B2 (en) | 2017-06-20 | 2021-01-05 | Ethicon Llc | Techniques for adaptive control of motor velocity of a surgical stapling and cutting instrument |
US10779820B2 (en) | 2017-06-20 | 2020-09-22 | Ethicon Llc | Systems and methods for controlling motor speed according to user input for a surgical instrument |
US11517325B2 (en) | 2017-06-20 | 2022-12-06 | Cilag Gmbh International | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured displacement distance traveled over a specified time interval |
US11653914B2 (en) | 2017-06-20 | 2023-05-23 | Cilag Gmbh International | Systems and methods for controlling motor velocity of a surgical stapling and cutting instrument according to articulation angle of end effector |
US10993716B2 (en) | 2017-06-27 | 2021-05-04 | Ethicon Llc | Surgical anvil arrangements |
USD906355S1 (en) | 2017-06-28 | 2020-12-29 | Ethicon Llc | Display screen or portion thereof with a graphical user interface for a surgical instrument |
US11564686B2 (en) | 2017-06-28 | 2023-01-31 | Cilag Gmbh International | Surgical shaft assemblies with flexible interfaces |
US11696759B2 (en) | 2017-06-28 | 2023-07-11 | Cilag Gmbh International | Surgical stapling instruments comprising shortened staple cartridge noses |
US10765427B2 (en) | 2017-06-28 | 2020-09-08 | Ethicon Llc | Method for articulating a surgical instrument |
US20190000459A1 (en) | 2017-06-28 | 2019-01-03 | Ethicon Llc | Surgical instruments with jaws constrained to pivot about an axis upon contact with a closure member that is parked in close proximity to the pivot axis |
EP3420947B1 (en) | 2017-06-28 | 2022-05-25 | Cilag GmbH International | Surgical instrument comprising selectively actuatable rotatable couplers |
US10932772B2 (en) | 2017-06-29 | 2021-03-02 | Ethicon Llc | Methods for closed loop velocity control for robotic surgical instrument |
US11944300B2 (en) | 2017-08-03 | 2024-04-02 | Cilag Gmbh International | Method for operating a surgical system bailout |
US10779826B2 (en) | 2017-12-15 | 2020-09-22 | Ethicon Llc | Methods of operating surgical end effectors |
US11179152B2 (en) | 2017-12-21 | 2021-11-23 | Cilag Gmbh International | Surgical instrument comprising a tissue grasping system |
DE202018001853U1 (en) | 2018-04-12 | 2018-06-14 | Lothar Sellin | Bioresorbable implant |
ES2930364T3 (en) | 2018-07-09 | 2022-12-09 | Japan Medical Device Tech Co Ltd | magnesium alloy |
JP2022028088A (en) * | 2018-12-12 | 2022-02-15 | 住友電気工業株式会社 | Stent and manufacturing method of stent |
US11696761B2 (en) | 2019-03-25 | 2023-07-11 | Cilag Gmbh International | Firing drive arrangements for surgical systems |
US11903581B2 (en) | 2019-04-30 | 2024-02-20 | Cilag Gmbh International | Methods for stapling tissue using a surgical instrument |
US11648009B2 (en) | 2019-04-30 | 2023-05-16 | Cilag Gmbh International | Rotatable jaw tip for a surgical instrument |
KR102626287B1 (en) * | 2019-06-03 | 2024-01-16 | 포트 웨인 메탈스 리서치 프로덕츠 엘엘씨 | Magnesium based absorbent alloy |
US11350938B2 (en) | 2019-06-28 | 2022-06-07 | Cilag Gmbh International | Surgical instrument comprising an aligned rfid sensor |
US11771419B2 (en) | 2019-06-28 | 2023-10-03 | Cilag Gmbh International | Packaging for a replaceable component of a surgical stapling system |
US11627959B2 (en) | 2019-06-28 | 2023-04-18 | Cilag Gmbh International | Surgical instruments including manual and powered system lockouts |
US11523822B2 (en) | 2019-06-28 | 2022-12-13 | Cilag Gmbh International | Battery pack including a circuit interrupter |
US11638587B2 (en) | 2019-06-28 | 2023-05-02 | Cilag Gmbh International | RFID identification systems for surgical instruments |
US11684434B2 (en) | 2019-06-28 | 2023-06-27 | Cilag Gmbh International | Surgical RFID assemblies for instrument operational setting control |
US11553971B2 (en) | 2019-06-28 | 2023-01-17 | Cilag Gmbh International | Surgical RFID assemblies for display and communication |
US11660163B2 (en) | 2019-06-28 | 2023-05-30 | Cilag Gmbh International | Surgical system with RFID tags for updating motor assembly parameters |
CA3146023A1 (en) | 2019-07-05 | 2021-01-14 | Iomx Therapeutics Ag | Antibodies binding igc2 of igsf11 (vsig3) and uses thereof |
CN110916747B (en) * | 2019-11-12 | 2022-07-26 | 山东瑞安泰医疗技术有限公司 | Absorbable zinc-copper alloy ligation clamp for solution treatment and preparation method thereof |
US11844520B2 (en) | 2019-12-19 | 2023-12-19 | Cilag Gmbh International | Staple cartridge comprising driver retention members |
US11576672B2 (en) | 2019-12-19 | 2023-02-14 | Cilag Gmbh International | Surgical instrument comprising a closure system including a closure member and an opening member driven by a drive screw |
US11504122B2 (en) | 2019-12-19 | 2022-11-22 | Cilag Gmbh International | Surgical instrument comprising a nested firing member |
US11701111B2 (en) | 2019-12-19 | 2023-07-18 | Cilag Gmbh International | Method for operating a surgical stapling instrument |
US11529139B2 (en) | 2019-12-19 | 2022-12-20 | Cilag Gmbh International | Motor driven surgical instrument |
US11911032B2 (en) | 2019-12-19 | 2024-02-27 | Cilag Gmbh International | Staple cartridge comprising a seating cam |
TWI719767B (en) * | 2019-12-19 | 2021-02-21 | 財團法人工業技術研究院 | Biodegradable iron-based alloy composition, medical implant applying the same, and manufactruing method thereof |
US11559304B2 (en) | 2019-12-19 | 2023-01-24 | Cilag Gmbh International | Surgical instrument comprising a rapid closure mechanism |
US11607219B2 (en) | 2019-12-19 | 2023-03-21 | Cilag Gmbh International | Staple cartridge comprising a detachable tissue cutting knife |
US11529137B2 (en) | 2019-12-19 | 2022-12-20 | Cilag Gmbh International | Staple cartridge comprising driver retention members |
USD976401S1 (en) | 2020-06-02 | 2023-01-24 | Cilag Gmbh International | Staple cartridge |
USD975850S1 (en) | 2020-06-02 | 2023-01-17 | Cilag Gmbh International | Staple cartridge |
USD975851S1 (en) | 2020-06-02 | 2023-01-17 | Cilag Gmbh International | Staple cartridge |
USD974560S1 (en) | 2020-06-02 | 2023-01-03 | Cilag Gmbh International | Staple cartridge |
US20240010720A1 (en) | 2020-07-06 | 2024-01-11 | Iomx Therapeutics Ag | Antibodies binding igv of igsf11 (vsig3) and uses thereof |
US20220031350A1 (en) | 2020-07-28 | 2022-02-03 | Cilag Gmbh International | Surgical instruments with double pivot articulation joint arrangements |
US11717289B2 (en) | 2020-10-29 | 2023-08-08 | Cilag Gmbh International | Surgical instrument comprising an indicator which indicates that an articulation drive is actuatable |
US11931025B2 (en) | 2020-10-29 | 2024-03-19 | Cilag Gmbh International | Surgical instrument comprising a releasable closure drive lock |
US11779330B2 (en) | 2020-10-29 | 2023-10-10 | Cilag Gmbh International | Surgical instrument comprising a jaw alignment system |
USD1013170S1 (en) | 2020-10-29 | 2024-01-30 | Cilag Gmbh International | Surgical instrument assembly |
US11896217B2 (en) | 2020-10-29 | 2024-02-13 | Cilag Gmbh International | Surgical instrument comprising an articulation lock |
US11844518B2 (en) | 2020-10-29 | 2023-12-19 | Cilag Gmbh International | Method for operating a surgical instrument |
USD980425S1 (en) | 2020-10-29 | 2023-03-07 | Cilag Gmbh International | Surgical instrument assembly |
US11617577B2 (en) | 2020-10-29 | 2023-04-04 | Cilag Gmbh International | Surgical instrument comprising a sensor configured to sense whether an articulation drive of the surgical instrument is actuatable |
US11534259B2 (en) | 2020-10-29 | 2022-12-27 | Cilag Gmbh International | Surgical instrument comprising an articulation indicator |
US11517390B2 (en) | 2020-10-29 | 2022-12-06 | Cilag Gmbh International | Surgical instrument comprising a limited travel switch |
US11653915B2 (en) | 2020-12-02 | 2023-05-23 | Cilag Gmbh International | Surgical instruments with sled location detection and adjustment features |
US11653920B2 (en) | 2020-12-02 | 2023-05-23 | Cilag Gmbh International | Powered surgical instruments with communication interfaces through sterile barrier |
US11744581B2 (en) | 2020-12-02 | 2023-09-05 | Cilag Gmbh International | Powered surgical instruments with multi-phase tissue treatment |
US11737751B2 (en) | 2020-12-02 | 2023-08-29 | Cilag Gmbh International | Devices and methods of managing energy dissipated within sterile barriers of surgical instrument housings |
US11944296B2 (en) | 2020-12-02 | 2024-04-02 | Cilag Gmbh International | Powered surgical instruments with external connectors |
US11890010B2 (en) | 2020-12-02 | 2024-02-06 | Cllag GmbH International | Dual-sided reinforced reload for surgical instruments |
US11678882B2 (en) | 2020-12-02 | 2023-06-20 | Cilag Gmbh International | Surgical instruments with interactive features to remedy incidental sled movements |
US11627960B2 (en) | 2020-12-02 | 2023-04-18 | Cilag Gmbh International | Powered surgical instruments with smart reload with separately attachable exteriorly mounted wiring connections |
US11849943B2 (en) | 2020-12-02 | 2023-12-26 | Cilag Gmbh International | Surgical instrument with cartridge release mechanisms |
CN112899527B (en) * | 2021-01-20 | 2022-04-08 | 湖南华锐科技集团股份有限公司 | Degradable zinc alloy bar and preparation method thereof |
DE102021103786B4 (en) | 2021-02-17 | 2023-07-20 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein | Implant for implantation in an organism and method |
US11744583B2 (en) | 2021-02-26 | 2023-09-05 | Cilag Gmbh International | Distal communication array to tune frequency of RF systems |
US11950779B2 (en) | 2021-02-26 | 2024-04-09 | Cilag Gmbh International | Method of powering and communicating with a staple cartridge |
US11793514B2 (en) | 2021-02-26 | 2023-10-24 | Cilag Gmbh International | Staple cartridge comprising sensor array which may be embedded in cartridge body |
US11812964B2 (en) | 2021-02-26 | 2023-11-14 | Cilag Gmbh International | Staple cartridge comprising a power management circuit |
US11749877B2 (en) | 2021-02-26 | 2023-09-05 | Cilag Gmbh International | Stapling instrument comprising a signal antenna |
US11751869B2 (en) | 2021-02-26 | 2023-09-12 | Cilag Gmbh International | Monitoring of multiple sensors over time to detect moving characteristics of tissue |
US11701113B2 (en) | 2021-02-26 | 2023-07-18 | Cilag Gmbh International | Stapling instrument comprising a separate power antenna and a data transfer antenna |
US11730473B2 (en) | 2021-02-26 | 2023-08-22 | Cilag Gmbh International | Monitoring of manufacturing life-cycle |
US11696757B2 (en) | 2021-02-26 | 2023-07-11 | Cilag Gmbh International | Monitoring of internal systems to detect and track cartridge motion status |
US11925349B2 (en) | 2021-02-26 | 2024-03-12 | Cilag Gmbh International | Adjustment to transfer parameters to improve available power |
US11723657B2 (en) | 2021-02-26 | 2023-08-15 | Cilag Gmbh International | Adjustable communication based on available bandwidth and power capacity |
US11950777B2 (en) | 2021-02-26 | 2024-04-09 | Cilag Gmbh International | Staple cartridge comprising an information access control system |
US11737749B2 (en) | 2021-03-22 | 2023-08-29 | Cilag Gmbh International | Surgical stapling instrument comprising a retraction system |
US11717291B2 (en) | 2021-03-22 | 2023-08-08 | Cilag Gmbh International | Staple cartridge comprising staples configured to apply different tissue compression |
US11826042B2 (en) | 2021-03-22 | 2023-11-28 | Cilag Gmbh International | Surgical instrument comprising a firing drive including a selectable leverage mechanism |
US11806011B2 (en) | 2021-03-22 | 2023-11-07 | Cilag Gmbh International | Stapling instrument comprising tissue compression systems |
US11826012B2 (en) | 2021-03-22 | 2023-11-28 | Cilag Gmbh International | Stapling instrument comprising a pulsed motor-driven firing rack |
US11723658B2 (en) | 2021-03-22 | 2023-08-15 | Cilag Gmbh International | Staple cartridge comprising a firing lockout |
US11759202B2 (en) | 2021-03-22 | 2023-09-19 | Cilag Gmbh International | Staple cartridge comprising an implantable layer |
US11786243B2 (en) | 2021-03-24 | 2023-10-17 | Cilag Gmbh International | Firing members having flexible portions for adapting to a load during a surgical firing stroke |
US11896218B2 (en) | 2021-03-24 | 2024-02-13 | Cilag Gmbh International | Method of using a powered stapling device |
US11896219B2 (en) | 2021-03-24 | 2024-02-13 | Cilag Gmbh International | Mating features between drivers and underside of a cartridge deck |
US11786239B2 (en) | 2021-03-24 | 2023-10-17 | Cilag Gmbh International | Surgical instrument articulation joint arrangements comprising multiple moving linkage features |
US11849944B2 (en) | 2021-03-24 | 2023-12-26 | Cilag Gmbh International | Drivers for fastener cartridge assemblies having rotary drive screws |
US11903582B2 (en) | 2021-03-24 | 2024-02-20 | Cilag Gmbh International | Leveraging surfaces for cartridge installation |
US11793516B2 (en) | 2021-03-24 | 2023-10-24 | Cilag Gmbh International | Surgical staple cartridge comprising longitudinal support beam |
US11744603B2 (en) | 2021-03-24 | 2023-09-05 | Cilag Gmbh International | Multi-axis pivot joints for surgical instruments and methods for manufacturing same |
US11832816B2 (en) | 2021-03-24 | 2023-12-05 | Cilag Gmbh International | Surgical stapling assembly comprising nonplanar staples and planar staples |
US11944336B2 (en) | 2021-03-24 | 2024-04-02 | Cilag Gmbh International | Joint arrangements for multi-planar alignment and support of operational drive shafts in articulatable surgical instruments |
US11857183B2 (en) | 2021-03-24 | 2024-01-02 | Cilag Gmbh International | Stapling assembly components having metal substrates and plastic bodies |
US11849945B2 (en) | 2021-03-24 | 2023-12-26 | Cilag Gmbh International | Rotary-driven surgical stapling assembly comprising eccentrically driven firing member |
US11890004B2 (en) | 2021-05-10 | 2024-02-06 | Cilag Gmbh International | Staple cartridge comprising lubricated staples |
US11826047B2 (en) | 2021-05-28 | 2023-11-28 | Cilag Gmbh International | Stapling instrument comprising jaw mounts |
CN113737056B (en) * | 2021-09-09 | 2022-05-27 | 湘潭大学 | Zn-Se-based alloy material and preparation method and application thereof |
US11937816B2 (en) | 2021-10-28 | 2024-03-26 | Cilag Gmbh International | Electrical lead arrangements for surgical instruments |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2094578A (en) * | 1932-09-13 | 1937-10-05 | Blumenthal Bernhard | Material for surgical ligatures and sutures |
US5843172A (en) * | 1997-04-15 | 1998-12-01 | Advanced Cardiovascular Systems, Inc. | Porous medicated stent |
US7879367B2 (en) * | 1997-07-18 | 2011-02-01 | Alfons Fischer | Metallic implant which is degradable in vivo |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB319886A (en) | 1928-08-20 | 1929-10-03 | Arthur Cloudesley Smith | Improved means applicable for use in surgery in sealing arteries, clipping tissues and the like |
GB1237035A (en) * | 1969-08-20 | 1971-06-30 | Tsi Travmatologii I Ortopedii | Magnesium-base alloy for use in bone surgery |
DE2303558C3 (en) | 1973-01-25 | 1978-11-23 | Howmedica, Inc., New York, N.Y. (V.St.A.) | Use of a corrosion-resistant implant alloy for implants in the blood vessel system |
US3905047A (en) * | 1973-06-27 | 1975-09-16 | Posta Jr John J | Implantable ceramic bone prosthesis |
DE2502884A1 (en) * | 1975-01-24 | 1976-07-29 | Juergen J Dipl Phy Hildebrandt | Synthetic bone or joint prosthesis - incorporates zones which are gradually absorbed by the body |
GB1602375A (en) | 1977-06-02 | 1981-11-11 | Johnson Matthey Co Ltd | Coating of metals |
GB8414123D0 (en) * | 1984-06-02 | 1984-07-04 | Castex Prod | Pharmaceutical pellet |
US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
NZ220024A (en) * | 1986-04-17 | 1989-05-29 | Castex Prod | Rumen bolus having carrier of magnesium associated with electrically conductive active matrix |
GB8620469D0 (en) | 1986-08-22 | 1986-10-01 | Atomic Energy Authority Uk | Prostheses |
US5059211A (en) † | 1987-06-25 | 1991-10-22 | Duke University | Absorbable vascular stent |
US5123917A (en) | 1990-04-27 | 1992-06-23 | Lee Peter Y | Expandable intraluminal vascular graft |
US5211663A (en) | 1991-06-24 | 1993-05-18 | Smith & Nephew Richards, Inc. | Passivation methods for metallic medical implants |
WO1994004166A1 (en) * | 1991-08-21 | 1994-03-03 | Silvia Cristina Vanderhoeven | Device to be placed in the vascular system to prevent or limit damage caused by diabetes |
DE4141977C2 (en) * | 1991-12-19 | 1994-11-24 | S & G Implants Gmbh | Endoprosthesis to replace a human hip joint |
US5489297A (en) | 1992-01-27 | 1996-02-06 | Duran; Carlos M. G. | Bioprosthetic heart valve with absorbable stent |
JP3415158B2 (en) * | 1994-05-09 | 2003-06-09 | シュナイダー・(ユーエスエイ)・インコーポレーテッド | Clad composite stent |
US5649977A (en) | 1994-09-22 | 1997-07-22 | Advanced Cardiovascular Systems, Inc. | Metal reinforced polymer stent |
EP0714640A1 (en) | 1994-11-28 | 1996-06-05 | Advanced Cardiovascular Systems, Inc. | System and method for delivering multiple stents |
US5637113A (en) | 1994-12-13 | 1997-06-10 | Advanced Cardiovascular Systems, Inc. | Polymer film for wrapping a stent structure |
DE19506188C2 (en) | 1995-02-22 | 2003-03-06 | Miladin Lazarov | Implant and its use |
US5681345A (en) | 1995-03-01 | 1997-10-28 | Scimed Life Systems, Inc. | Sleeve carrying stent |
US5980252A (en) * | 1995-05-08 | 1999-11-09 | Samchukov; Mikhail L. | Device and method for enhancing the shape, mass, and strength of alveolar and intramembranous bone |
DE29603027U1 (en) | 1995-06-03 | 1996-05-02 | Scholz Werner | Temporary or permanent implant made of a metal alloy |
JPH09140783A (en) | 1995-11-21 | 1997-06-03 | Kobe Steel Ltd | Implant member for living body and its production |
US6027528A (en) | 1996-05-28 | 2000-02-22 | Cordis Corporation | Composite material endoprosthesis |
JP4422215B2 (en) | 1997-02-20 | 2010-02-24 | クック インコーポレイテッド | Coated implantable medical device |
US5891507A (en) | 1997-07-28 | 1999-04-06 | Iowa-India Investments Company Limited | Process for coating a surface of a metallic stent |
DE19856983A1 (en) | 1998-06-25 | 1999-12-30 | Biotronik Mess & Therapieg | Implantable, bioresorbable vascular wall support, in particular coronary stent |
DE59913189D1 (en) | 1998-06-25 | 2006-05-04 | Biotronik Ag | Implantable, bioabsorbable vessel wall support, in particular coronary stent |
US6335029B1 (en) | 1998-08-28 | 2002-01-01 | Scimed Life Systems, Inc. | Polymeric coatings for controlled delivery of active agents |
SE9804536D0 (en) | 1998-12-23 | 1998-12-23 | A & Science Invest Ab | Biological implant and method of production thereof |
DE29908768U1 (en) | 1999-05-19 | 1999-08-12 | Starck Bernd | Highly flexible cover for stents and / or stent-crafts and / or stent-vascular prostheses |
DE19950386A1 (en) | 1999-10-19 | 2001-05-10 | Miladin Lazarov | Biocompatible item |
US7604663B1 (en) | 1999-12-30 | 2009-10-20 | St. Jude Medical, Inc. | Medical devices with polymer/inorganic substrate composites |
-
1997
- 1997-07-18 DE DE19731021A patent/DE19731021A1/en not_active Withdrawn
-
1998
- 1998-07-17 AU AU91541/98A patent/AU9154198A/en not_active Abandoned
- 1998-07-17 AT AT98943732T patent/ATE236667T1/en not_active IP Right Cessation
- 1998-07-17 EP EP05005740.5A patent/EP1552856B1/en not_active Expired - Lifetime
- 1998-07-17 PT PT02019905T patent/PT1270023E/en unknown
- 1998-07-17 WO PCT/EP1998/004415 patent/WO1999003515A2/en active IP Right Grant
- 1998-07-17 DE DE59807846T patent/DE59807846D1/en not_active Expired - Lifetime
- 1998-07-17 IL IL12906598A patent/IL129065A0/en active IP Right Grant
- 1998-07-17 DE DE59812873T patent/DE59812873D1/en not_active Expired - Lifetime
- 1998-07-17 JP JP50644199A patent/JP5352776B2/en not_active Expired - Lifetime
- 1998-07-17 US US09/269,084 patent/US7879367B2/en not_active Expired - Fee Related
- 1998-07-17 EP EP98943732A patent/EP0923389B1/en not_active Expired - Lifetime
- 1998-07-17 ES ES98943732T patent/ES2200368T3/en not_active Expired - Lifetime
- 1998-07-17 DK DK02019905T patent/DK1270023T3/en active
- 1998-07-17 EP EP02019905A patent/EP1270023B2/en not_active Expired - Lifetime
- 1998-07-17 ES ES02019905T patent/ES2243635T3/en not_active Expired - Lifetime
- 1998-07-17 AT AT02019905T patent/ATE297767T1/en not_active IP Right Cessation
-
1999
- 1999-03-18 IL IL129065A patent/IL129065A/en not_active IP Right Cessation
-
2005
- 2005-12-07 IL IL172424A patent/IL172424A/en not_active IP Right Cessation
-
2009
- 2009-09-10 JP JP2009208920A patent/JP2009297537A/en active Pending
-
2010
- 2010-10-05 US US12/897,967 patent/US20110251669A1/en not_active Abandoned
- 2010-11-05 JP JP2010249076A patent/JP2011031063A/en active Pending
-
2011
- 2011-08-17 US US13/211,921 patent/US8771751B2/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2094578A (en) * | 1932-09-13 | 1937-10-05 | Blumenthal Bernhard | Material for surgical ligatures and sutures |
US5843172A (en) * | 1997-04-15 | 1998-12-01 | Advanced Cardiovascular Systems, Inc. | Porous medicated stent |
US7879367B2 (en) * | 1997-07-18 | 2011-02-01 | Alfons Fischer | Metallic implant which is degradable in vivo |
Non-Patent Citations (2)
Title |
---|
Braunersreuther et al., Statins and stent thrombosis, Swiss Medical Weekly (2012), Vol. 142, pp. 1-9. * |
Sawyer, P.N. et al., "Development and In Vivo Evaluation of Metals for Heart Valve Prostheses", vol. XIII Trans. Amer. Soc. Artif. Int. Organs, 1967, pp. 124-130. * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10960110B2 (en) * | 2018-08-21 | 2021-03-30 | Jian Xie | Iron-based biodegradable metals for implantable medical devices |
Also Published As
Publication number | Publication date |
---|---|
IL129065A (en) | 2006-04-10 |
EP0923389A3 (en) | 2002-08-28 |
EP0923389B1 (en) | 2003-04-09 |
ES2200368T3 (en) | 2004-03-01 |
ATE297767T1 (en) | 2005-07-15 |
EP1270023B2 (en) | 2012-04-11 |
US8771751B2 (en) | 2014-07-08 |
ES2243635T3 (en) | 2005-12-01 |
WO1999003515A2 (en) | 1999-01-28 |
EP1552856A1 (en) | 2005-07-13 |
IL129065A0 (en) | 2000-02-17 |
US20020004060A1 (en) | 2002-01-10 |
PT1270023E (en) | 2005-10-31 |
DE59812873D1 (en) | 2005-07-21 |
ATE236667T1 (en) | 2003-04-15 |
DK1270023T3 (en) | 2005-09-05 |
JP2011031063A (en) | 2011-02-17 |
EP0923389A2 (en) | 1999-06-23 |
IL172424A (en) | 2008-08-07 |
US20110301694A1 (en) | 2011-12-08 |
US7879367B2 (en) | 2011-02-01 |
JP5352776B2 (en) | 2013-11-27 |
EP1270023B1 (en) | 2005-06-15 |
JP2009297537A (en) | 2009-12-24 |
EP1270023A2 (en) | 2003-01-02 |
AU9154198A (en) | 1999-02-10 |
EP1552856B1 (en) | 2015-10-07 |
WO1999003515A3 (en) | 1999-08-05 |
JP2001511049A (en) | 2001-08-07 |
EP1270023A3 (en) | 2003-12-17 |
DE19731021A1 (en) | 1999-01-21 |
DE59807846D1 (en) | 2003-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8771751B2 (en) | Metallic implant which is degradable in vivo | |
US8840736B2 (en) | Endoprosthesis comprising a magnesium alloy | |
EP2398521B1 (en) | Bioerodible endoprosthesis | |
US6287332B1 (en) | Implantable, bioresorbable vessel wall support, in particular coronary stent | |
US8372144B2 (en) | Implant with a base body of a biocorrodible iron alloy | |
JP4523179B2 (en) | Biomedical aids or implants | |
US8268235B2 (en) | Implant with a base body of a biocorrodible magnesium alloy | |
US20060052864A1 (en) | Endoprosthesis comprising a magnesium alloy | |
US8888842B2 (en) | Implant made of a metallic material which can be resorbed by the body | |
US20100087911A1 (en) | Implant with a base body of a biocorrodible manganese alloy | |
US20100292776A1 (en) | Bioerodible Endoprosthesis | |
JP2012523286A (en) | Bioerodible implantable medical device incorporating supersaturated magnesium alloy | |
US9427500B2 (en) | Stent made of a cobalt alloy | |
EP0367354A1 (en) | A percutaneous implant | |
EP1484079A1 (en) | Stent for intracranial vascular therapy and process for producing the same | |
Xujun et al. | Shape-Memory Alloy for Interventional Stenting in View of its Development in China |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BIOTRONIK SE & CO. KG, GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HAUSDORF, JAQUELINE, MS;HEUBLEIN, EVA, DR.;FISCHER, ALFONS, PROF;SIGNING DATES FROM 20120416 TO 20120424;REEL/FRAME:030634/0563 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |